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Abstract 
Mammalian lungs are composed of millions of tiny air sacs called alveoli where gas 
exchange takes place. The inner surface of alveoli is coated by an aqueous layer to 
prevent it from drying up. However, because the attraction between water molecules is 
stronger than the force between water and air, a surface tension is created at the air-water 
interface. The tension tends to collapse the alveoli and increase the work of breathing. 
Lung surfactant is a material that counteracts these tendencies by reducing the surface 
tension to extremely low values and thus prevents the alveolar collapse and also eases the 
work of breathing. The lung surfactant material is a mixture of lipids and proteins. 
Surfactant Protein B (SP-B) is an essential component of the surfactant and is thought to 
function by facilitating large-scale rearrangement of the lipid molecules and stabilizing 
the structures. However, neither the structural basis for this ability nor the physiological 
ramifications of lipid rearrangements are yet understood. SP-B is a lipid-associated 
hydrophobic protein, which makes it difficult to address with X-ray or conventional 
solution NMR structural techniques. These difficulties have been addressed in NMR 
structural studies by the use of fluorinated organic solvents and lipid micelles to 
solubilize the proteins. The present work has focused on SP-BcTERM and Mini-B, two 
peptide fragments of SP-B that retain significant biological activity of the full-length 
protein. The structural features of these peptides were studied using high-resolution 
solution NMR. Firstly, the conformational features of SP-BcTERM and its interactions with 
lipids were investigated in micelles mimicking the lipid environment in the lungs. The 
peptide exhibited the ability to cause aggregation of micelles formed from lipids similar 
to those found in lungs. This was indicative of the large-scale lipid rearrangement and 
stabilization of structures facilitated by SP-B in natural surfactant. In the second and main 
phase of current research, the structure of Mini-B was determined in the structure-
inducing fluorinated organic solvent hexafluoroisopropanol (HFIP). The peptide was 
found to consist of two a-helices at the termini connected by an unstructured loop at the 
middle. These studies help to define the structural properties that underlie SP-B's 
function and provide a platform to probe the lipid-protein interactions that are responsible 
for the ability of lung surfactant to dramatically lower the surface tension at the air-water 
interface in alveoli. 
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Chapter 1 
Introduction 
1.1 Lung Surfactant 
Living orgamsms need a continuous supply of oxygen to perform various 
physiological activities and also need to get rid of carbon dioxide produced in metabolic 
reactions. For air-breathing vertebrates, blood carries both of these gases with the 
exchange taking place in the lungs. This function of lungs is accomplished through 
airways ending in tiny air sacs known as alveoli. Adult human lungs contain 
approximately 2400 kilometers of airways and 300 million alveoli, having a total surface 
area of about 140m2. Alveoli are surrounded by capillaries carrying blood and the barrier 
in between is extremely thin, allowing for rapid Oz/COz exchange (Figure 1.1 ). The inner 
surface of the alveoli is coated by an aqueous layer to prevent it from drying up due to its 
constant contact with air. 
Alveolus 
Figure 1.1 : Schematic diagram of human respiratory system. 
The lungs, and thereby the alveoli, inflate and deflate cyclically with inhalation 
and exhalation. These fluid coated air sacs are roughly spherical in shape. Maintaining 
their structure during cyclical changes in lung volume is critical for normal respiration. 
Since the attraction between water molecules is stronger than that of water and air, a 
surface tension is created at the air-water interface in the alveoli. This is largely governed 
by LaPlace's law that relates the fluid pressure, P, inside a spherical vessel of radius R 
with the surface tension, T; 
T =RP/2 
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The surface tension, unless countered, would promote lung-collapse and increase the 
work required to re-inflate the lung at the end of expiration [1]. However, it is countered 
by a material called lung surfactant (also known as pulmonary surfactant). Lung 
surfactant is a mixture of lipids and proteins that lines the air-water interface in the 
alveoli. Pure water has a surface tension of about 70 mN/m. By interfering with the 
interaction of the surface water molecules, the surfactant lowers it down to an equilibrium 
value of 25 mN/m in the lungs, which is further reduced to almost 0 mN/m during 
expiration [2]. This prevents alveolar collapse at the end of exhalation and also eases the 
work of breathing during subsequent inhalation. This behavior of the surfactant has been 
termed as the surface activity. 
Lung surfactant was first discovered by von Neergaard in the late-1920s [3]. 
However, the significance of the discovery was not appreciated at that time. In the mid-
1950s, surfactant's ability to reduce surface tension led to its rediscovery by Pattie [ 4] 
and Clements [5]. Since then, extensive research has been conducted to explore the 
molecular mechanisms that underlie its physiological function. Over the years, important 
advancements have been made. However, a complete molecular description of the 
structures of the components and their interactions during the respiratory dynamics are 
still unavailable. 
1.2 Surfactant Source and Composition 
The alveolar fluid coating has a thickness of about 2 ~-tm. Lung surfactant is 
synthesized and secreted into the alveolar fluid by some of the boundary-forming cells of 
the alveoli, known as Type II cells (Figure 1.2). These cells are cuboidal in shape and 
contain specialized secretory intermediaries known as lamellar bodies (LB) [6]. An LB is 
the storage form of the surfactant. It consists of a core composed of multilamellar 
membranes surrounded by another membrane [7]. It is secreted in response to local 
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biochemical factors [8], signals from the automatic nervous system [9] and deep 
breathing [10] or stretch [11]. In the aqueous environment, the LB contents become 
hydrated and can unravel into tubular myelin (TM). The TM is an ordered array of 
tubules of nearly rectangular cross section. The walls of the TM have bilayer form and 
the corners are either intersecting or very closely apposed bilayers with very high 
curvature. Some models for surfactant formation assume TM as the immediate precursor 
of the surface film. Surfactant components are released from it and form a surface active 
film at the air-water interface [12, 13]. The surfactant film has long been considered as a 
simple monolayer. However, recent electron-microscopic and surface activity studies 
suggest that actually several layers are closely packed at the interface [ 14 - 16]. 
surfactant film 
Alveolar 
Type II cell 
Air 
Figure 1.2 : One model describing 
the formation of lung surfactant [13, 
16]. Components are synthesized 
in the endoplasmic reticulum (ER), 
transported to golgi apparatus (GA) 
and packed in lamellar bodies (LB). 
LB, being secreted into the liquid 
layer (Hypophase), swells and 
unravels to form tubular myelin 
(TM). TM supplies surfactant lipids 
and proteins to the surface film. 
Lung surfactant is a complex mixture of lipids (~ 90% by weight) and proteins 
(~ 10% by weight). Phospholipids make up the bulk of the surfactant materials(~ 80%) 
but there are some neutral lipids ( ~ 10%) as well. Composition varies significantly 
between different mammalian and nonmammalian species and also throughout the 
physiological development of a particular species [17]. Table 1.1 lists the names of the 
components of human lung surfactant with the percentage of share by weight [ 17, 18]. 
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Table 1.1 : Components of human lung surfactant [17, 18] 
Neutral.lipids·( ~ 1 0%). 
1. maitHy Cholesterel,~ lp% 
2. minor amounts of mono, di and triglycerides 
3:. minor f~J11qunt of free. fatty. acids 
1.3 Surfactant Biophysical Activity 
An effective surfactant exhibits two critical properties. Firstly, it adsorbs very 
rapidly to the air-water interface, producing equilibrium surface tensions of around 25 
mN/m within seconds [2, 16]. This ensures that the surfactant reaches the respiratory 
interface before a newborn completes the first inspiration, so that alveolar collapse can be 
avoided by reducing the surface tension at the end of the subsequent expiration. Secondly, 
once adsorbed at the interface, the surfactant must reduce the surface tension to values 
close to 0 mN/m upon compression [5]. This, in addition to avoiding lung collapse at the 
end of expiration, eases the work of next inspiration. 
Since its rediscovery in the mid-1950s, lung surfactant has been subjected to 
various analytical and experimental techniques, but the molecular mechanisms 
underpinning its functions are not yet known in detail. There are lots of unanswered 
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questions regarding the structures, roles and mechanisms adopted by each individual 
components at different stages. However, based on various in vitro biophysical studies, a 
few models have been proposed. The models suggest that the phospholipids, due to their 
ability to form oriented interfacial monolayers, act as the principal surface active agents 
in the surfactant. However, the two properties mentioned above seemed to be mutually 
exclusive in single phospholipid systems. Phospholipids exhibiting rapid adsorption and 
spreading properties (e.g., POPC) are not capable of lowering surface tensions when the 
formed monolayers are compressed [19]. Conversely, phospholipids achieving extremely 
low surface tensions at mono layers following compression (e.g., DPPC) adsorb very 
slowly from the hypophase [18]. Thus, the solution to obtaining optimal performance 
appears to be a mixture of suitable phospholipids. During inspiration, some of the lipid 
components ensure rapid adsorption, formation and replenishment of the surface-active 
film. Then in subsequent expiration, other lipid components provide the low 
compressibility necessary to achieve stable low surface tension. 
The protein components are also essential for the surfactant to function properly. 
The proteins are primarily considered as modulating agents, evolved to optimize the 
surface activity of the phospholipids during the respiratory cycle. However, one of the 
proteins, namely SP-B, plays such crucial roles that in its absence the surfactant loses its 
surface activity and fails to function. SP-B and some other proteins also produce dramatic 
acceleration of the interfacial adsorption and speed the process further under certain 
circumstances [8]. Thus, the mixture of lipids and proteins has been evolutionally 
optimized in lung surfactant to perform all the required tasks simultaneously [18]. 
1.4 Surfactant Disorder- Disease and Treatment 
Deficiency or absence of functional lung surfactant leads to potentially fatal 
health conditions such as respiratory distress syndrome (RDS). This is a common 
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problem in premature newborns, as well as in adults with acute injury or illness. The 
development of lung surfactant replacement treatments in the early 1990s has greatly 
improved the outlook for newborns with RDS [19]. However, use of surfactant 
replacement techniques in addressing RDS for adults is still under development [20]. The 
need for more efficacious therapies is thus obvious. Clinical trials have demonstrated that 
artificial surfactants which include the proteins SP-B and SP-C are much more effective 
than protein-free surfactant preparations [22]. 
1.5 Surfactant Lipids 
The roles of the major lipid components of the lung surfactant in surface activity 
have been identified but those of the minor lipid species are less-well characterized. Also 
to be noted is that, most of the experimental focus has been on surface tension reducing 
properties of the surfactant. The lipid components, however, could also be involved in 
other metabolic aspects of the surfactant life cycle [23]. 
During expiration, surfactant film at the alveolar air-water interface is compressed 
and the surface tension must be reduced to the order of 0-1 mN/m [5]. This means that 
the surfactant film sustains surface pressure close to 70 mN/m at the interface. 
Experiments on monolayers composed of the major surfactant phospholipids led to the 
conclusion that only pure DPPC film is capable of withstanding such high pressure [24]. 
This is because the saturated acyl chains of DPPC can be packed tightly enough to 
sustain the highest pressure. Thus DPPC acts as the most vital component of the 
surfactant. However, this phospholipid adsorbs very poorly by itself into the interface, 
especially at temperatures below its gel-to-liquid crystalline phase transition temperature 
of 41 °C [25]. 
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Mixing with more fluid phospholipids, such as unsaturated PCs, PG and/or PI, 
improves the adsorption of DPPC to a large extent [23]. However, lipids alone do not 
make fully functional surfactant. The hydrophobic proteins SP-B and SP-C boost the 
adsorption substantially, but the mechanisms involved are yet to be understood. 
Nevertheless, most of the components of surfactant other than DPPC are considered to 
facilitate both its adsorption to the interface and its re-spreading in the successive 
respiratory cycles [18]. 
Another lipid element of the surfactant, present in mentionable amount, is 
cholesterol. The ability of cholesterol to alter essential properties of membranes is well-
established but no clear data are available to date to evaluate its actual role in lung 
surfactant. 
1.6 Surfactant Proteins 
The protein portion of lung surfactant comprises four proteins SP-A, SP-B, SP-C 
and SP-D. The names of the proteins were given with respect to their chronological order 
of discovery. SP-A is the most abundant among the proteins in surfactant. Its main role is 
thought to be in defending the lungs against germs. Experiments showed that the mice 
born without SP-A could breathe normally but were extremely prone to developing 
infections [26]. In vitro and in vivo studies also showed that SP-A plays important role in 
the formation of tubular myelin [27]. It has further been observed that SP-A can improve 
the surface activity of surfactant under challenging conditions such as low surfactant 
concentrations and presence of inhibitory plasma proteins or oxidants [18]. SP-B fulfils a 
crucial role since hereditary deficiency of this protein is lethal in humans [28] and in 
knockout mice [29]. Deactivation of SP-B by antibodies also causes RDS in vivo [30]. 
SP-C deficiency is not lethal at birth but its absence modifies biophysical properties of 
monolayers [31]. It is associated with familial interstitial lung disease [32]. The exact 
7 
roles played by SP-B and SP-C in surfactant function and the mechanisms by which they 
act are not yet known. However, experiments showed that the presence of SP-B and SP-C 
provide necessary enhancement in adsorption of phospholipids at the alveolar air-water 
interface [33]. These proteins also seem to be important to prevent detaching of the 
folded structures from the water layer [18]. SP-D is not associated with surface active 
lipid-protein complexes and is not considered to play any significant roles in mechanisms 
of reducing surface tension at air-water interface [18]. 
The main structural properties of the surfactant proteins are listed in Table 1.2 
[16]. It should be noted that the overall 3D structures of these proteins have not been 
determined thus far and the schematic models shown here are based on preliminary 
assumptions. 
Table 1.2 : Structural features of the lung surfactant proteins [16] 
Model 
structure 
Phospholipid DPPC 
binding 
Anionic/zwitterionic Anionic PI 
phospholipid~;" phospholipids 
1. 7 Surfactant Protein B (SP-B) 
SP-B is the most important among the protein components of the surfactant as it is 
essential for survival. In mammalian lung, it is found as a covalently linked homodimer 
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having molecular mass of about 18 kDa [34]. Human SP-B monomer is 79 residues 
(amino acids) in length [35]. However, the SP-B gene is first transcribed and translated 
into a significantly larger precursor consisting of 381 residues. The mature form of SP-B 
consists of residues 201-279 of the precursor. This is cleaved in compartments that lie 
between the trans-golgi and the lamellar body [36]. Table 1.3 lists the amino acid 
sequence of human SP-B. 
Table 1.3 : Amino acid sequence of human surfactant protein B 
17-32 Arg-Ile-Gln-Ala-Met-:Ile-Pro.;.Lys-Gly-Ala-Leu-Ala-Val-Ala-Val-Ala-
49-64 Leu-Ala-Glu-Arg-Tyr-Ser-Val-lle.;.Leu-Len~ Asp-Thr.:Leu-Leu'"Gly-Arg-
Compared to water soluble proteins, a large portion (about 60%) of SP-B's amino 
acids are hydrophobic, which are alanine, valine, leucine, isoleucine, methionine, 
cysteine, phenyalanine and tryptophan. There are seven cysteines, six of which form 
three intra-molecular disulfide bridges and the remaining one forms an inter-molecular 
bond responsible for dimerization. SP-B also exhibits a strong cationic profile as it 
contains nine positively charged (arginine & lysine) and two negatively charged 
(aspartate & glutamate) residues yielding a net charge of+ 7 at neutral pH. 
The properties of SP-B which have been identified in vitro include, membrane 
binding, membrane lysis, membrane fusion, promotion of lipid adsorption to air-water 
surfaces, stabilization of monomolecular surface films and re-spreading of films from 
collapsed phases [36]. All these activities point to SP-B's ability to make large-scale lipid 
rearrangements that are assumed to be crucial in surfactant function. However, the details 
of SP-B's essential roles in vivo are still far from being understood. 
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The teniary (O\eroll 30) and "'"" lhe oecondal) (u-bclix/1}-shutlloop.rum!ooil) 
structure of the full-lenglh SP-B ha> not )et been detennined_ Ho,.e><r, some inference 
can be drawn from proteins with similar amino acid sequence whose s1rucrures ha"·e 
alreody been determined. SI'-B belongs to lhe Saposin protein superfamily. 
Experimentally derived structures of four members of this superfomily, namely Saposin 
ll (PDB entry IN69 (37]). Saposin C (PDB entry ISN6 [38]), NK-Lysin (PDB entry 
I NKL (39)) and Amoebopore (POB cnlr) IOF9 (40]), display four (or the) dominant 
helical regions although lhe way lhe helices are packed toeether can differ. Sequence 
homology "'ilh these proteins suuestslhat SP-B likely consists of four or fhe u-bclices 
connected by loops (Figure 1.3 (A)). 
• 
F~ure 1.3: SctlematiC tff)tHtnt.atlon.a of the 
models for SP·B and itt tuncuon•lly actrve 
fragments. (A) Fut~longlh SP B. (B) and 
(C) . HeliCe$ ato rti>,_IOd by II:) and 
<houtfide bonds ao S - S N and C re* 1o tile two 
IOrmn d tile p«>>ein/popOdl. -blrely 
Iii 
1.8 SP-B Fragments and Their Activity 
Fragments ofSP-B containing individual helices or pairs of helices were shown to 
retain significant biological activity of the full-length protein. SP-Bcmt"' (also ltnown as 
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SP-B63-78) is composed of amino acids 63-78 of SP-B and contains the C-terminal helix 
(Figure 1.3 (B)). Mini-B is made up of amino acids 8-25 and 63-78 of the native protein 
and contains both theN- and C-terminal helices linked by a loop (Figure 1.3 (C)). Mini-B 
can be produced with and without the disulfide bonds linking the two helices. 
Measurements of blood oxygen content of surfactant deficient rats treated with 
various artificial surfactants have demonstrated that SP-B peptides retain significant 
biological activity (Figure 1.4) [personal communication from Alan Waring]. The 
artificial surfactants were composed from lipids alone and lipids plus SP-B, Mini-B or 
SP-BcTERM. Treatment with lipids alone did not improve the oxygen content in blood. 
Lipids + SP-BcTERM improved it almost by half of that of lipids + SP-B. Lipids + Mini-B 
performed as well as the lipids + SP-B. The findings indicate that these peptides, 
especially Mini-B, retain vital functional properties of native SP-B. This points to the 
likelihood that Mini-B contains functionally active regions of the full-length protein. 
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Figure 1.4 Relative performance of different artificial lung surfactants applied on surfactant 
deficient rats. Treatment with only lipids did not improve the oxygen content in blood. 
However, lipids with SP-8 peptides, especially Mini-8, showed significant improvement. 
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1.9 Previous Structura l Studies of SP-B Peptides 
Sl.ruelurcs of IWo SP-B peplides eonlaining the 1wo 1cm1inal re11ions of the full-
lenglh protein have previously been detennined by NMR. The structure of the 15 residue 
N-tcrminal peptide. SP-B"·"• has been detennined in Ori!JIIlic solvent methanol by Kurtz 
tt a/ (PDB entty I KMR [41 [).The structures of the 16 residue C-tenninal peptide, SP-
s..,. (called earlier and la~er as SP-Be-nw). have been detennined in micelles formed 
from Sodium Dodecyl Sulphate (SDS) as well .. in orpnic soh-ent 
hexalluoroisopropanol (HFIP) by Booth t1 al (PDB entries I RG3 and 1 RG4 (42)). 
Kuru. eta/. detennined the strueiUre of SP-Bn.u in methanol using solution NMR 
[41}. The structure showed that the peptide consists of an a-helix (Figure 1.5), running 
through amino acids 13 to 21. The C-terminus of SP-8,,., was found to be disordered. 
N c Flguno 1.5 : EnMmblo ol10towest 
ener;y-atruc:llnO of SP-8,..,. 
oniMtllanOI!'IJ (0--
from Proloon O.W &.nk. to 1KMRJ. 
The pepbde conl81n1 en fl-helix 
from amino ec.dt 1 3 to 2 1 with a 
disordered C&term•nut 
Booth et al detennined the structures of SP-S.,.11 in two different environments 
[421 The organic solvent sample "as prepared by dissolvina 2 m\.1 SP-B.,.n in 40'4 
IIFIP. 5~ H:O and 10'1. 0,0 "'th 0.2 rn.\1 DSS. The sample had pH of 3.0 and the 
l'.MR dalll .,.,..., acquired at 5 •c. The lipid micelle sample was prepared b) mixing 2 
m\1 peptide, 200 mM deuterated SDS and 0.2 mM DSS in 90'1• 11,0 and 10'/o 0,0. The 
>Omple had pH of 6.9 and the NMR experiments were performed at 25 °C. The studies 
showed that the structure of the peptide is mostly a -helical in both the environments. the 
a-helix runs through amino acids 68 to 78 in HFIP and 69 to 78 in SDS (Figure 1.6). 
However, 1he N-1enninal region ofSP-B.,.n was found disordered in HFIP. 
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c 
c 
N 
Figure 1.6 : Ensembles of 10 lowest energy ribbon structures of sp.s.,.,. in (A) HFIP and (8) 
SDS micelle (42). (Doagrams lal<en from Protein Data Bank, IDs 1RG4 and 1RG3). The peptide 
contains an o~helix from amino acids 68 to 78 in HFIP and from amino acids 69 to 78 in SOS. 
The N-termmal region of the peptide 1S disordeted m HFIP . 
1.10 Objectives of the Present Work 
The present NMR structural studies were conducted to 
(i) probe the interactions of SP·IkTERM with the micelle-forming analogs of the 
physiological surfactant phospholipids, and 
(ii) determine the structure ofMini·B in structure-promoting organic solvent HFIP. 
A protein's biological function comes about due to the organiza[ion of its amino 
acid chain into a specific, well-folded, 30 structure. Hence, detennination of the structure 
of SP-B will provide a basis for understanding its function. However. SP·B is a lipid· 
associaled and exceptionally hydrophobic protein, making it difficult to address with 
conventional X-ray or solution NMR structural techniques. Besides, it is very hard to 
express the full-length SP-B in bacteria or synthesize it chemically. Therefore. initial 
structural studies were carried out with two chemically synthesized segments (peptides). 
SP-i3<:T£kM and Mini-B. that retain significant biological activity comparable to the full· 
length protein. The structural features of these peptide'S provided impOrtant indications 
ahout how the full-length SP·B works in native conditions. 
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Chapter 2 
Protein NMR 
Spectroscopy 
2.1 Protein Structure 
A protein is a polymer composed of a long chain of chemical subunits called 
amino acids (also known as residues). There are 20 different types of amino acids that are 
commonly found in proteins [43]. All of them have the same backbone chemical structure 
(- N - Ca - C - ). Three of the substituents of Ca are identical for every amino acid. The 
difference lies in the fourth substituent, the sidechain (or R group). (Figure 2.1 (A)). 
Individual atoms in an amino acid are referred to as HN, Ca, Ha, C~, H~, etc. Amino acids 
are linked into a linear sequence by peptide bonds between the carboxyl C of one residue 
and the amino N of the next residue (Figure 2.1 (B)). The first and the last residues in the 
chain are termed as theN- and C-terminal residues, respectively. 
Backbone 
H Ha. ",/ 0 -1 
Residue1+1 II Residue1+2 lf-
HN Ha. 0 HN Ha. 0 HN Ha. 0 
Residue1 
H- -c-c I I II I I II I I II "'-$/ 
/ "' -H ®, 0 
"' Side-chain 
·····N-~a:-C···\··N-ra:-7C:.····N-ra:-C····· IRiJ IR1+1I Hli1 C~- H~2 
Peptide Bond 6 
H51yC~ I v,C52H521 
/ I H I ' 
H512 H v H H622 
613 623 
[Backbone 
Side-chain 
Figure 2.1 : Chemical structure of a protein. (A) A single amino acid. All 20 amino acids have 
same backbone chemical structure (- N - Ca - C -) but different side-chains (Rs). (B) Amino 
acids are connected by peptide bonds to form a full-length protein. Residue1+2 is shown with the 
names of the side-chain nuclei as an example. 
There are four levels of protein structure; primary, secondary, tertiary and 
quaternary. The amino acid sequence of the polypeptide chain is called the primary 
structure. Different regions of the chain form local regular secondary structures, such as 
a-helices and ~-strands. The tertiary structure is formed by packing such structural 
elements into one or more compact globular units (domains). The final protein may 
contain several polypeptide chains arranged in a quaternary structure. It is the overall 3D 
structure of a protein that leads to function [ 44]. 
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2.2 Protein Structure Determination 
Proteins play numerous crucial physiological roles in living organisms. Since the 
function of a protein depends on its 3D structure, knowledge on the structural features is 
a precondition to understand the functional properties. Only two methods are available 
for determining the structure of a protein at atomic resolution; X-ray crystallography and 
nuclear magnetic resonance (NMR) spectroscopy [45]. 
X-ray crystallography requires the protein to be grown as a well-ordered crystal 
[ 46]. A pattern of X-rays diffracted by the protein crystal is recorded. An electron density 
map is then generated into which the known sequence is fitted. This method calculates 
the atomic coordinates precisely. However, it can only provide information about one of 
the low-energy conformations that the protein may adopt but nothing regarding the 
dynamics. Therefore, the structure may sometime be misleading and may lack 
physiological relevance. Furthermore, for lipid-associated membrane proteins, it is 
virtually impossible (with rare exceptions) to grow diffraction-quality crystals due to the 
problems caused by aggregation. 
NMR spectroscopy has only been developed as a technique for protein structure 
determination in the last two and a half decades. The first complete 3D structure solved 
using this technique was presented in 1986. Although solid-state NMR can be used to 
obtain some structural information, high-resolution protein structures are determined by 
NMR mainly in solution state. NMR method exploits the quantum mechanical property 
of spin 1/2 nuclei. The sample is placed in a strong static magnetic field and the spin 1/2 
nuclei CH, 13C, 15N, etc.) of the protein are perturbed by specific radiofrequency (RF) 
pulses. High-resolution structural data are generated by manipulating the magnetization 
through scalar and dipolar couplings. The data contain information on inter-nuclear 
distances and backbone dihedral angles which are used to compute the structural model 
of the protein. 
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In addition to providing structural data, high-resolution solution NMR can also be 
used to study the flexibility of proteins and their dynamics over a wide range of time 
scales. This method also enables the study of membrane proteins in lipid micelles which 
mimick the physiological environment. However, the inherent properties of solution 
NMR impose a limitation on the size of the protein that can be studied. For standard 
triple resonance techniques, the size is limited typically to 200 residues. 
2.3 Basic Principles of NMR 
Nuclear magnetic resonance (NMR) is a phenomenon which occurs when a group 
of nuclei with nonzero spin angular momentum is immersed in a static magnetic field and 
exposed to RF pulses of certain specific energy. Nuclei with zero spin (e.g., 12C or 160) 
are thus not observable by NMR. Nuclei with spin 1 (e.g., 2H or 14N) are also not 
generally useful for structural studies in solution. They possess quadrupole moments and 
the lifetimes of their magnetic states are very short resulting in broad resonance lines 
which are difficult to observe. Nuclei with spin 1/2 (such as 1H) are the most useful ones 
for high-resolution solution NMR [45]. For biomolecular structural studies, 12C and/or 
14N nuclei of the molecule are often replaced by their isotopes 13C and/or 15N, 
respectively, which are spin 112 nuclei. 
In the absence of any external magnetic field, the spin 1/2 nuclei of a sample, 
which may be considered as tiny bar magnets, do not have any preferred orientation. 
However, if the sample is placed in a large static external magnetic field, quantum 
mechanical requirements mean that all the nuclei take one of the two allowed states, 
given by the magnetic quantum number m = ± 1/2. The two states have different energy 
levels known as Zeeman levels (Figure 2.2). In thermal equilibrium, these states are 
unequally populated, having some more nuclei in the lower energy state than the higher, 
as determined by the Boltzmann distribution. The small nuclear magnets may 
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spontaneously flip from one orientation (energy state) to the other but the rate is 
extremely slow. However, if energy equal to that of the difference between the two states 
is applied, much more flipping is induced. This is an example of resonance phenomena 
and hence given the name Nuclear Magnetic Resonance (NMR) [ 4 7]. 
Bo 
No Magnetic Field Applied Field 80 E = -yl'lBo/2 
m = +1/2 
m 
m = -1/2 
E = +yl'lBo/2 
Magnetic Field 
Figure 2.2 : Energy levels of a spin 1/2 nucleus in an external magnetic field. (A) The applied 
field 80 causes the energy state of the nucleus to be splitted into two levels (Zeeman levels). 
(B) The nucleus assumes one of the two quantum mechanically allowed energy values and 
transition occurs by the absorption or emission of energy equal to the difference of the two states. 
A nucleus with spm angular momentum I also possesses nuclear magnetic 
moment JA., and the relation between the two is 
II =yl 
Here y is the proportionality constant known as the gyromagnetic ratio of the nucleus. 
The magnitude of y, in part, determines the receptivity of a nucleus in NMR spectroscopy. 
The larger the gyromagnetic ratio the stronger the NMR signal is. Now, the magnitude of 
the spin angular momentum is 
I=mh 
Here h = h!2Jt and h is Planck's constant. Therefore, the nuclear magnetic moment is 
!! = ymh 
Again, in an external magnetic field B, the spin states of a nucleus have energies given by 
E =- J.t.B 
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The energy of a particular spin state m is then 
Em=-mhyB 
Thus the energy difference between the two Zeeman levels of a spin 1/2 nucleus placed 
in an external static magnetic field Bo is 
~E=yhBo 
This is also the irradiation energy required to cause Zeeman transition between the two 
states. Now the Bohr condition 
~E=hv 
enables the frequency of the nuclear transition, known as Larmor frequency, to be written 
as vo = (1/2n:)yBo or wo = yBo 
in units of Hz or rad/s, respectively. Hence, the irradiation energy depends on both y and 
Bo. In practice, it is in the radiofrequency (RF) range and is typically applied as a short 
pulse [47]. 
Table 2.1 lists the gyromagnetic ratios and the Larmor frequencies of selected 
NMR-active nuclei in an 11.74 T field [45, 48]. 
Table 2.1 : Properties of nuclei commonly used in NMR [45, 48) 
The Zeeman splitting of the magnetic states of the spin 1/2 nuclei in an external 
magnetic field also causes a net bulk magnetization M 0 to evolve as the two states are 
unequally populated. It is this net magnetization that determines the NMR signal, not the 
magnetic moment of an individual nucleus. Conventionally the direction of the applied 
field Bo is taken as the z-axis of the coordinate system, so, Mo also evolves along z-axis. 
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m 
Figure 2.3 : Steps of a simple one-pulse NMR experiment. In a static external field 8 0 , the net 
bulk magnetization M0 lies along z-axis (A). A 90° pulse applied along the y-axis rotates M0 to the 
x-axis making it M(:n:/2) having the same magnitude (B). Relaxation starts immediately as M(:rc/2) 
precesses in the xy-plane under the influence of 8 0 . The time-varying magnetic field M(t) induces 
a current in the spectrometer coil (C). The free induction decay (FID) is recorded during the 
acquisition period that starts at the end of the pulse (D). However, the FID is a time-domain signal. 
The real component of the complex frequency domain NMR spectrum is obtained by Fourier 
transformation of the FID (E). 
During NMR experiments (Figure 2.3), the net magnetization Mo is manipulated 
by an RF pulse, which is a time varying magnetic field Bt, oscillating at the same Larmor 
frequency w0. Often, B1 is a 90° pulse and applied along y-axis. This applies a torque on 
the bulk magnetization and tips it along x-axis into the xy-plane. In this situation, the 
bulk magnetization rotates about the z-axis with frequency Wo under the influence of Bo 
and induces an electric current in the detection coil of the spectrometer. In the absence of 
any further perturbing RF pulses, relaxation processes eventually return the spin system 
to thermal equilibrium with the magnetization oriented back along the z-axis. During this 
period, the transverse magnetization decays with time. The corresponding free induction 
decay (FID) is recorded for a certain period. However, the FID is a time-domain signal 
with contributions typically from many different nuclei having slightly different 
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frequency. The usual frequency-domain spectrum is obtained by computing the Fourier 
transform of the FID. 
2.4 Basic NMR Parameters 
Relaxation Times (T 1 and T 2) : Relaxation is the process by which a nuclear spin 
system, perturbed by absorbing an RF energy, returns back to thermal equilibrium. There 
are two relaxation processes; spin-lattice or longitudinal relaxation, characterized by the 
time Tt and spin-spin or transverse relaxation, characterized by the time T2 [49]. At 
equilibrium, the net magnetization vector, Mo, lies along the z-axis, so there is no 
transverse component and the longitudinal component represents the total magnetization, 
i.e., Mz = Mo and Mx =My = 0 (Figure 2.4 (A)). A 90° RF pulse with appropriate energy 
and phase rotates the magnetization and over time (of the order of 1 0 I-tS) diminishes Mz 
to zero (Figure 2.4 (B)). After the pulse, the spin system gradually (of the order of 1 s for 
a typical protein) returns back to the equilibrium and Mz regains its original value. The 
time constant which describes how Mz returns to its equilibrium value is called the spin-
lattice relaxation time (T 1). The equation governing this behavior as a function of time t 
after the displacement is 
Mz(t) = Mo (1 - e-trr1) 
Again, when the net magnetization is rotated to the XY -plane by the application of a 90° 
RF pulse, it evolves as transverse magnetization and precesses in the plane under the 
influence of the static external field. However, immediately it starts to dephase (fan out) 
(Figure 2.4 (C)). Fluctuating fields which perturb the energy levels of the spin states 
cause the transverse magnetization to dephase. The longer the elapsed time, the greater 
the phase difference is. The time constant that describes how the transverse 
magnetization, Mxv, returns to its equilibrium value, Mxy0, is called the spin-spin 
relaxation time (T 2). This is governed by 
Mxy(t) = MxYo e-trr2 
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Figure 2.4 : The net magnetization M0 at different stages. (A) In static magnetic field 8 0 , Mz = Mo. 
(B) A 90° RF pulse 8 1 rotates the magnetization into the xy-plane. (C) The magnetization starts to 
diphase immediately due to fluctuations in the magnetic fields. 
In reality both the T 1 and T 2 processes occur simultaneously, the only restriction being 
that T2 is always less than or equal to Tt. Following a pulse sequence that perturbs the 
spin system from equilibrium, T 2 governs the length of time during which the FID can be 
observed and Tt governs the minimum time required for equilibrium to be restored. T2 
plays a crucial role in protein NMR. It is inversely proportional to the overall rotational 
correlation time (tc) of the protein and thus depends on the mass and shape of the 
molecule. There are actually two factors that contribute to the decay of transverse 
magnetization; mutual exchange of spin energies (said to lead to a pure T2 molecular 
effect) and variations in the static external field Bo (said to lead to an inhomogeneous T2 
effect). The combination of these two factors is what actually results in the decay of 
transverse magnetization. The combined time constant is called T 2 * and is expressed as 
1/T 2 * = 1/T 2 + 1/T 2inhomo 
Typical values ofTt. T2 and 'tc for proteins in solution are 1, 0.05 and 10"9 s, respectively. 
Chemical Shift : In NMR spectroscopy, nuclei of different elements, having different 
gyromagnetic ratios, yield signals at different frequencies when placed in a particular 
external magnetic field (Table 2.1). However, the observed resonance frequencies also 
depend on the local chemical environments that the individual nuclei find themselves in 
and differ slightly from the frequencies predicted by 
Wo =yBo 
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The difference between the predicted and observed resonance frequencies is referred to as 
a chemical shift. It offers the possibility of distinguishing between nuclei in different 
chemical environments. This phenomenon arises because motions of electrons induced 
by the external magnetic field generate secondary fields. The net local magnetic field 
experienced by a nucleus results from the combination of the external and the secondary 
fields. The effect of the secondary field, called nuclear shielding, can enhance or oppose 
the main field. Depending on the chemical environment around the nucleus, each nucleus 
experiences a slightly different degree of shielding resulting in the variation in local 
magnetic fields [ 45, 50]. Consequently, the resonance condition is modified to 
oo = yB1ocai = yBo(l- a) 
where oo is the effective resonance frequency due to the actual local field B1ocai 
experienced by the nucleus and a is a nondimensional screening or shielding constant. 
However, it is difficult to determine the resonance frequency of a nucleus with absolute 
accuracy. It is rather easier to determine the difference between the resonance frequencies 
of a nucleus of interest and a reference [ 45]. Since the induced secondary field that causes 
the chemical shift is about a million times weaker than the applied main static field, the 
chemical shift is expressed in terms of parts per million (ppm). This also removes the 
dependence of the chemical shift on applied magnetic field strength and makes it a 
dimensionless number 6 (Figure 2.5) given by 
6 = [( OOint- OOref )/ooo] X 106 
in which OOint and OOref are the frequencies of the signal of interest and the reference signal, 
respectively, and oo0 is the operating frequency of the spectrometer. In practice the 
reference signal is set to 0 ppm so that OOref = roo. The most commonly used reference 
compounds are tetramethylsilane (TMS) and sodium 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS). TMS is used as an external reference while DSS is used as an internal 
reference [45]. 
Scalar Coupling : Scalar interactions (through-bond) between nuclei linked via a small 
number of covalent bonds in a chemical structure result in mutual splitting of the NMR 
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signal from each nucleus into multiplets (Figure 2.5) [47]. It occurs because the nuclei are 
coupled through interactions mediated by the electrons forming the chemical bonds 
between the nuclei. This coupling is ordinarily not important beyond three bonds. The 
two-bond coupling is termed as geminal (e.g., H-C-H) while the three-bond one as vicinal 
(e.g., H-C-C-H). To a first approximation, the relative intensities of the multiplets are 
given by binomial coefficients; 1:1 for a doublet (i.e., a nucleus interacting with another 
nucleus), 1:2:1 for a triplet (i.e., a nucleus interacting with two other equivalent nuclei) 
and 1:3:3:1 for a quartet (i.e., a nuclei interacting with three other equivalent nuclei). The 
difference between any two adjacent components of a multiplet is the same and yields the 
value of the spin-spin coupling constant J (in Hz). This is independent of the magnetic 
field strength. To simplify a protein spectrum and to improve the signal to noise (SIN) 
ratio, decoupling is often employed by irradiating the nuclei coupled to the observed 
nuclei with a weak RF field. 
Coupling Constant Jac 
~ 
Coupling Constant Jac 
~ T Amplitude 
Llnewidth 
Reference 
~~----------ob-------------~ l--oc~ 
~---------------------~------------------------~ 
Chemical Shifts Bo----+ 
Figure 2.5 : Basic NMR spectral parameters. The reference signal is assigned a chemical shift of 
0 ppm. The chemical shifts of the other signals are measured from the reference and named as 
ba and so on. The height of a signal represents its amplitude and the area under the curve 
represents its intensity which is proportional to the number of nuclei contributing to the signal. The 
coupling constant represents the difference between two adjacent multiplets which results from 
scalar coupling. 
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Linewidth : In an NMR spectrum a series of absorption peaks or signals, representing 
resonance frequencies of the nuclei in different chemical environments, are observed. 
The area of a signal (not the height) is directly proportional to the number of nuclei 
contributing to the signal under suitable experimental conditions. The linewidth (W 112) is 
defined as the full-width at half-height of the resonance line shape (Figure 2.5) [47]. It is 
a primary factor affecting both resolution and SIN ratio of the spectrum. It is directly 
related to the spin-spin or transverse relaxation time T 2 by 
W112 = lhtT2 
The relaxation time, however, is inversely proportional to the overall rotational 
correlation time (tc) of the molecule in solution. Again, 'tc depends on mass and shape of 
the molecule. Thus, observed linewidths significantly larger than expected primarily 
indicate increase in rotational correlation time caused by molecular aggregation. If 
aggregates are large enough, the lines become too broad to observe. 
Nuclear Overhauser Effect (NOE) : The NOE is the fractional change in intensity of 
one NMR line when another resonance is irradiated in a double irradiation experiment 
[51]. It is customarily quoted in percent of the unperturbed resonance intensity. The 
NOEs are observed because of the dipolar cross-relaxation (through-space) between pairs 
of nuclei (protons) with sufficiently close spatial proximity (usually < 5 A). NOE 
intensity is proportional to the inverse sixth power of the distance between the two nuclei 
and given by 
NOE = f(dynamics) x 1/r6 
Thus the NOEs observed between pairs of protons in a protein characterize inter-proton 
distances that are invaluable for the 3D structure determination. Another application of 
this effect is the information on protein dynamics since the NOE is a function of the 
dynamics too. The dynamics arise from the conformational changes in proteins while 
performing their specific functions. With the NOE experiment for each amino acid, the 
rigidity and flexibility of the local backbone conformation of a protein can be determined 
in a quantitative manner [52]. 
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2.5 Protein NMR Experiments 
Complex multi-dimensional, as well as simple one-dimensional, NMR 
experiments are performed for the purpose of protein structure determination. Proton ( 1 H) 
is the most useful nucleus in this context because of its large natural abundance and large 
gyromagnetic ratio (Table 2.1 ). However, 13C or 15N nuclei are also used in protein NMR 
by replacement of their natural isotopes e2c and 14N). The structure determination 
process begins with identifying which resonance frequency belongs to which magnetic 
nucleus in the chemical structure of the protein. Afterwards, NOEs are used to identify 
pairs of protons that are close in space. The NOE data is combined with molecular 
dynamics simulation to provide the 3D atomic coordinates of the protein. 
aliphatic 
backbone HN Ha. 
10 8 6 4 2 
1H chemical shift (ppm) 
0 
Figure 2.6 : Schematic 
representation of 1 D 1 H 
NMR spectrum of a 
protein. Chemical shift 
ranges observed for the 
various types of proton 
resonances are shown. 
In a simple lD 1H experiment, the net magnetization that evolves along the z-axis 
is rotated into the xy-plane by a 90° RF pulse of sufficient power for a few microseconds. 
At the end of the pulse, the transverse magnetization decays and the data acquisition 
begins by recording the FID. The time domain FID is then Fourier-transformed to yield 
the frequency domain spectrum. Because the resonance frequency is modulated by the 
chemical environment that a 1 H finds itself in, the 1 D spectrum shows a dispersion of 
signals obtained from protons at different positions in various amino acids. However, a 
25 
group of protons at similar positions in all amino acids (e.g., amide protons or a-protons) 
has a characteristic range of frequencies and hence the chemical shifts (Figure 2.6) [45]. 
The second basic experiment, the proton-detected 2D Heteronuclear Single 
Quantum Correlation (HSQC), uses a magnetization transfer mechanism. For this 
experiment, at least some the 12C and/or 14N nuclei must have been replaced by their spin 
1/2 isotopes 13C and/or 15N during the protein production. 13C will not be mentioned any 
further as only 15N labels were used for present studies. The magnetization is transferred 
from covalently linked 1H to 15N during the mixing period that precedes the acquisition. 
The peaks in the spectrum correlate the frequencies of 15N_IH pairs of nuclei (Figure 2.7). 
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Figure 2.7 : Schematic representation 
of2D 15N-1H HSQC Sftectrum for a 
protein with selected 5N-Iabeled 
residues. The peaks correlate the 
resonance frequencies of covalently 
linked 15N- 1H pairs of nuclei. Ra, Rb, 
Rc and R~ represent peaks from four 
different 5N-Iabeled amino acids. 
The lD 1H and 2D HSQC experiments are routinely done to optimize the sample 
conditions (concentration, pH, temperature, etc.) and to check the status of the sample 
before and after any complex multidimensional experiments. The spectra also indicate the 
homogeneity of the protein's structure, molecular aggregation, etc. Preliminary hints on 
secondary structure ( a-helix/!3-sheet) may also be obtained as a particular proton group 
(especially the backbone amide protons) exhibits characteristic shifts in frequency with 
respect to that of random coil configuration. 
To determine a protein's structure, the resonance frequency of each magnetic 
nucleus must be determined. For that, a number of multidimensional homonuclear and 
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heteronuclear experiments are performed which eventually lead to the complete 
resonance assignments. 
2D Total Correlation Spectroscopy (TOCSY) and Nuclear Overhauser-Effect 
Spectroscopy (NOESY) are the standard homonuclear experiments for identifying spin• 
spin coupling connectivities between pairs of protons. These experiments rely on 
magnetization transfer from one proton to the next, which takes place during a part of the 
pulse sequence called the mixing time. In TOCSY, the magnetization is transferred from 
one proton to another through covalent bonds using scalar coupling (up to 3 bonds). In 
NOESY, the magnetization transfer is achieved through space using dipolar coupling (up 
to - 5 A). The diagonal peaks of these 2D spectra reproduce the complete lD 1H 
spectrum. The off-diagonal cross-peaks, on the other hand, correlate pairs of protons 
between which the magnetization has been transferred (Figure 2.8, only selected few 
peaks are shown for clarity). 
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Figure 2.8 : Schematic representations of 20 homonuclear NMR spectra for a protein. 
(A) TOCSY, in which the cross-peaks (red) result from the magnetization transfer between 
protons through covalent bonds (up to 3 bonds). (B) NOESY, in which the cross-peaks result from 
the magnetization transfer between protons through space (up to - 5 A). NOESY generates 
peaks from both intra-residue (red) as well as sufficientlY, close inter-residue (green) proton-pairs. 
The diagonal peaks (blue) represent complete 1 D H spectrum in both. The spectra are 
symmetrical with respect to the diagonal. 
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The NOEs (observed as the cross-peaks in NOESY spectrum) act as the primary 
source of structural information in NMR, as they indicate the spatial proximity of protons 
within the molecule. The intensities of the NOEs vary approximately as the inverse sixth 
power of the inter-proton distances. However, there are difficulties in using the NOE 
intensity quantitatively since the intensity is also affected by spin diffusion, intra-protein 
motions and artifacts. Therefore, all the NOE intensities are classified into three 
categories (strong, medium and weak) and a set of distance restraints is developed. This 
set of distance restraints act as the most crucial input in the protein structure calculation. 
Additional restraints are derived from experiments that are sensitive to backbone 
dihedral angles. Double Quantum Correlated Spectroscopy (DQCOSY) measures the 
scalar coupling between the HN and Ha, the strength of which depends on the dihedral 
angle <j>. The frequencies of the resonances (and hence the chemical shifts) are sensitive to 
the secondary structure and can be used in combination with databases of structures and 
chemical shifts to predict backbone dihedral angles [50, 53]. Information on secondary 
structure obtained by other methods, such as Fourier Transform Infrared (FTIR) 
Spectroscopy, may also be used to generate H-bond restraints between different residues. 
As 2D homonuclear spectra are crowded with cross-peaks (especially the 
NOESY), overlapping of peaks often provide significant hindrance to resonance 
assignments. 3D and 4D heteronuclear-edited NMR experiments resolve overlapped 
cross-peaks according to the chemical shift ofthe heteronuclei (e.g., 15N) bonded directly 
to the 1H spins [54, 55]. In 3D experiments, the spectrum is separated along a third 
dimension ( 5N or 13C), so that the signals are distributed in a cube instead of a plane. 
This spreading-out is achieved by combining an HSQC at the end of a TOCSY /NOESY 
in a single experiment. The acquisition starts after the HSQC instead of at the end of the 
TOCSY/NOESY [56]. A 4D experiment consists of the concatenation of a NOESY pulse 
sequence and two HSQC building blocks. The peaks in the 4 D spectra are first separated 
with respect to one heteronuclei to generate 3D cubes which are then sliced further with 
respect to the other heteronuclei attached to 1 H spins. 
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2.6 Protein Structure Calculation 
Protein structure is calculated using computer programs that convert proton-
proton distance and dihedral angle data (restraints) into 3D molecular coordinates. The 
calculated structure reflects both the experimental data, as well as restrictions on bond 
lengths, angles, etc. that are known from the chemical structure of the protein. Both the 
NMR data and chemical structure data are implemented as empirical energy functions. In 
practice, an extended initial structure with ideal covalent geometry is generated first, 
using the known amino acid sequence. The computer program then attempts to refold the 
initial structure in a way such that the experimentally determined inter-proton distances 
are satisfied. To achieve this, each known parameter is assigned an energy potential. The 
program calculates a structure by minimizing the overall energy [57]. 
Without the experimentally determined distance and dihedral angle restraints 
from the NMR spectra, the protein can adopt a huge number of conformations that are 
still consistent with the covalent geometry imposed by its chemistry. It is therefore 
important to identify as many restraints as possible from the NMR spectra to restrict the 
conformational space to the subset of space actually sampled by the protein. 
Simulated annealing, combined with the molecular dynamics simulation, is the 
most commonly used method for calculating NMR structure of a protein in solution. In 
this method, an initial structure is heated to a high temperature in a simulation giving the 
atoms a high thermal mobility. During the subsequent cooling steps, the initial structure 
can evolve towards the energetically favorable final structure under the influence of a 
force field derived from the restraints [58]. The total energy is classified into two 
categories and given by, 
with 
and 
ETotal = EEmpirical + EExperimental 
EEmpirical = Eaond + EAngle + Evan-der-Waals + EEJectrostatic 
EExperimental = ENoE + Eoihedral + EH-bond 
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The structures are calculated using these energy functions and the simulated annealing 
protocol which finds the sets of coordinates that minimize the total energy [48]. 
ENoE, the pseudo energy term corresponding to the NOEs, plays crucial role in 
protein structure calculation. However, the NOE-derived inter-proton distances are 
imprecise. Therefore, many closely related structural models are consistent with the 
observations. Hence, NMR structures of proteins are usually reported as ensembles of 
atomic coordinates and the conformational space sampled by the ensemble reflects the 
conformational space sampled by the protein in solution. 
2. 7 Strategies for Hydrophobic Proteins 
Hydrophobic proteins are not water soluble. SP-B is a lipid-associated 
hydrophobic protein and hence presents unique challenges to structure determination by 
solution NMR. However, in solution NMR, detergent or lipid micelles can be used to 
mimic the lipid environment in which SP-B functions in the lungs (Figure 2.9). A micelle 
is an aggregate of lipid molecules, usually of globular shape, in a polar solvent (mostly 
water). These lipid molecules contain a polar (hydrophilic) head group and one long or 
two short nonpolar (hydrophobic) tail(s) (acyl chain(s)). When the lipid concentration in 
water is greater than a certain value, known as the critical micellar concentration (CMC), 
spherical structures called micelles are formed spontaneously by exposing the hydrophilic 
head groups to water molecules and burying the hydrophobic tails inside. 
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Figure 2.9 : Schematic representation 
of lipid micelle and protein/peptide. 
When mixed in water in excess of CMC, 
lipids with single acyl chain or short 
double acyl chains form spherical 
micelles. The membrane or lipid-
associated proteins/peptides settle on 
the micelles which may resemble the 
physiological situations. 
However, the lipid-protein complex is significantly bigger than the size of the 
protein itself. The larger complex tumbles more slowly which leads to more efficient 
transverse relaxation. Faster transverse relaxation rates lead in turn to broader lines in the 
NMR spectra and consequent decreases in the SIN ratio, as well as increases in peak 
overlap. The relaxation slows down because of the higher rotational correlation time 
which in turn broadens the resonance linewidths affecting both the resolution and the SIN 
ratio. As a result, the micelle data of protein/peptide is time consuming to analyze 
compared to data acquired in solvent. 
Organic solvents provide an alternative means to solubilize hydrophobic proteins 
such as SP-B for solution NMR studies. However, the structure of the protein in organic 
solvent is unlikely to resemble its lipid-associated structure. Hence, both organic solvent 
as well as micelles formed from different lipids have been employed for the structural 
studies of SP-B peptides (SP-BcTERM and Mini-B). 
In the first phase of this research, the conformational properties of SP-BcTERM and 
its ability to bind micelles together were studied in four different lipid micelle systems. 
The spectral features were compared with that obtained by Booth et al. while determining 
the structures of SP-BcTERM in hexafluoroisopropanol (HFIP) and sodium dodecyl 
sulphate (SDS) [42]. The lipids used were dodecylphosphocholine (DPC), lysophospha-
tidylglycerol (LPG), lysophosphatidic acid (LPA) and dihexanoylphosphatidylcholine 
(DHPC), which are micelle-forming analogs of natural lung surfactant lipids PC and PG 
(Figure 2.1 0). PCs are the most abundant phospholipids in the surfactant. They have two 
acyl chains connected to a zwitterionic head that contains both positively and negatively 
charged chemical groups. DPC (Figure 2.1 OA) has a similar zwitterionic head region as 
PC but it has one acyl chain. LPG (Figure 2.1 OB) contains similar anionic (negatively 
charged) head group as PG but again has one acyl chain. LP A (Figure 2.1 OC) also 
possesses an anionic head group and a single acyl chain. The head group of LP A is not 
similar to that of any surfactant lipids, but this was still chosen to see the response of the 
cationic (positively charged) SP-BcrERM in an anionic environment additional to LPG. 
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DHPC (Figure 2.1 OD) has two short acyl chains but the head group is completely 
analogous to that of PC. 
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Figure 2.10 : Micelle-forming analogs of the lung surfactant phospholipids (shown in the insets) 
used to study the conformational features of SP-BcrERM. (A) dodecylphosphocoline (DPC), 
(B) lysophosphatidylglycerol (LPG), (C) lysophosphatidic acid and (LPA) and dihexanoylphos-
phatidylcholine (DHPC). 
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While preparing the samples, each of the lipids were mixed in HzO/DzO in 
amount above the CMC to ensure the spontaneous formation of micelles. Table 2.2 lists 
some basic properties of the micelles formed from the lipids used in present work 
including that of SDS, which is the most commonly used detergent to form micelles for 
NMR structural studies of proteins [59- 65]. 
Table 2.2 : Properties of the micelle-forming lipids used to study SP-BcTERM [59- 65] 
Molecules/Micelle 70 56 125 Not available 40 
In the second and main phase of the research, the structure of the other SP-B 
peptide, Mini-B, was determined in deuterated organic solvent HFIP (Figure 2.11). Two 
fluorinated alcohols, tri-fluoro-ethanol and methanol, have been the most common 
organic solvents used for protein structure determination. However, HFIP has been found 
to offer better homogeneity of the protein conformation and the sample remains stable 
over longer periods. Therefore, HFIP was chosen for Mini-B structure determination. 
This research provided the first detailed structural characterization of Mini-B. This will 
also work as a primary database for any future NMR structural studies of Mini-B in lipid 
micelle systems. 
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Figure 2.11 :Molecular 
structure of organic solvent 
hexafluoroisopropanol 
(HFIP) used to determine 
the structure of Mini-B. 
Chapter 3 
SP-BctERM - Lipid 
Interactions 
3.1 Overview of Structural Studies of SP-BcTERM 
Structures of SP-BcTERM were determined earlier by Booth et al. [42] in both 
organic solvent HFIP and lipid micelles formed from SDS. The first phase of the present 
research was originally intended to investigate the conformational features of this peptide 
in more physiologically relevant environments than HFIP and SDS. Four different lipids 
(DPC, LPG, LPA and DHPC) were chosen for the purpose (see Section 2.7, Figure 2.10). 
These lipids form micelles in water and are single acyl chain or short double acyl chains 
analogs of phospholipids found in the natural lung surfactant. 
The investigations began with simple NMR experiments (1D 1H and 2D 15N- 1H 
HSQC) of SP-BcTERM in DPC, LPG, LPA and DHPC micelles. The spectra indicated 
aggregation of micelles, resulting in large complex sizes not amenable to study by 
solution NMR. To assess the basic structural properties of the peptide in presence of the 
aggregation, Circular Dichroism (CD) was used, in collaboration with David Heeley 
(Department of Biochemistry, MUN). In order to directly observe the aggregation 
implied by the NMR spectra, Dynamic Light Scattering (DLS) data were collected, in 
collaboration with Qi Wang (Agriculture and Agri-Food Canada). Overall, the results 
indicated that SP-BcTERM induced huge aggregation of LPG and LPA micelles, 
significant aggregation of DPC micelles and maybe some aggregation of DHPC micelles. 
This result is very relevant to SP-B's function in lungs where it is thought to be important 
in reorganizing lipid materials and stabilizing the structures at different stages of 
surfactant's life cycle. 
To underline the umqueness of SP-BcTERM's interactions with lipids, similar 
studies were also performed with the peptide RP-1. RP-1 possesses similar topological 
features to SP-B. It consists of a single helix which is hydrophobic on one face and 
hydrophilic on the other, and has several positively charged residues. At least in DPC, 
RP-1 did not induce the aggregation of micelles that was observed with SP-BcTERM. 
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3.2 Materials and Methods 
SP-BcTERM is a 16 residue peptide that contains most of the C-teminal region of 
human SP-B. It consists of amino acids 63 -78 of the full-length protein. The amino acid 
sequence is : 
Gly-Arg-Met-Leu-Pro-Gln-Leu-Val-Cys-Arg-Leu-Val-Leu-Arg-Cys-Ser 
1 5 10 15 
The peptide had six 15N labels at leucines 4, 7, 11 and 13 and valines 8 and 12, i.e., the 
natural isotope 14N of those residues at the backbone was replaced by 15N which is a spin 
112 nucleus. The peptide has two cysteines and three positively charged Arginines. 
The peptide was synthesized chemically by Alan Waring (UCLA), following the 
solid phase peptide synthesis method [42]. Materials (organic solvents and other reagents) 
used for the synthesis and purification of SP-BcTERM were high performance liquid 
chromatography (HPLC) grade or better (Fisher Scientific, Aldrich Chemical). 0-
fluorenylmethyl-oxycarbonyl (Fmoc) chemistry was employed for synthesizing the 
peptide. Fmoc amino acids were supplied by AnaSpec. The 15N-labeled amino acids were 
obtained from Cambridge Isotope Laboratories and converted to their Fmoc derivatives 
also by AnaSpec. After synthesis, the molecular weight of the peptide was confirmed by 
fast atom bombardment or MALDI-TOF mass spectrometry and the purity(> 95%) was 
determined by analytical HPLC. The purified peptide was lyophilized (powdered by 
cooling in liquid nitrogen) and stored at 4 °C. 
All the four NMR samples of SP-BcTERM in lipid micelles were prepared by 
mixing 1.5 mM peptide, 150 mM lipid and 0.4 mM DSS in 90% HzO and 10% DzO. The 
peptide was weighed out in dry form assuming it was 100% pure. DSS was used to obtain 
the proton reference signal at 0 ppm and DzO was used to provide the lock nucleus 
(deuterium) to the field-frequency lock system of the spectrometer. The volume of the 
sample was 600 ~-tL for each. To avoid any undesired folding of the peptide resulting 
from disulfide bonds between cysteines (both intra- and inter-chain), the pH of the 
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samples were set below 7. The pH was measured by an accumet Electrode bought from 
Fisher Scientific. 
The lipids were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL) and the 
DSS and D20 were purchased from Cambridge Isotope Laboratories, Inc. (Andover, MA). 
The NMR experiments (ID 1H and 2D 15N_IH HSQC) for SP-BcTERM were 
performed on a Bruker A vance 500 MHz spectrometer of Centre for Chemical Analysis, 
Research and Training (C-CART) at Memorial University ofNewfoundland (MUN). The 
spectrometer was equipped with z-gradients and triple-resonance TXI probes. 
Presaturation and flip-back water suppression methods were used for 1D 1H and 2D 
HSQC experiments, respectively. The spectra were processed using the software 
NMRPipe 2.2 [66]. 
The CD spectra for two SB-BcTERM samples (in DPC and LPG) were obtained 
using a Jasco J-81 0 spectropolarimeter of Heeley Lab at MUN. The CD samples were 
prepared by taking portions of NMR samples and diluting these about 103 times. 
Experiments were done at 25 °C using light path of 2 nm taking 2 accumulations with 
scanning speed of 100 run/sec. The DLS spectra for DPC samples (with and without the 
peptide) were acquired by a DLS system of Agriculture and Agri-Food Canada, Guelph. 
The DLS samples maintained the same material concentrations and experimental 
conditions as NMR. 
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3.3 NMR Spectra of SP-BcTERM in DPC Micelles 
The first lipid micelle system used to study the conformational and micelle-
binding features of SP-BcTERM was formed by the zwitterionic lipid DPC (a single chain 
analog of DPPC). The sample had a pH of 5.5 and the initial NMR experiments were 
done at 25 °C. 
The lD 1H spectrum of SP-BcTERM in DPC is shown in Figure 3.1. Corresponding 
spectra obtained earlier by Booth et al. for the peptide in HFIP and SDS are shown in the 
insets. Comparison of the backbone HN regions ( ~ 6.5 - 8.5 ppm) indicate that the 
spectrum of SP-BcTERM in DPC did not show dispersion of resonance signals at a level 
comparable to the spectra of SP-BcTERM in HFIP and SDS. The signals were also weaker 
as shown by the numbers corresponding to the intensities of the highest signals in HN 
regions normalized by the number of scans. The intensity of the signal in DPC is over 5 
times weaker than that in HFIP and about 4 times weaker than that in SDS. 
The 2D 15N-1H HSQC spectra of SP-BcTERM obtained in DPC is shown in Figure 
3 .2. Corresponding spectra obtained earlier by Booth et al. for the peptide in HFIP and 
SDS are also shown. The peptide had six 15N-labeled amino acids. The spectra in HFIP 
and SDS showed the expected six peaks corresponding to those amino acids. However, 
the spectrum in DPC showed more than six peaks. Also the peaks in DPC were weaker 
by factors of about 50 and 5, respectively, than what were observed in HFIP and SDS, as 
shown by the numbers representing the contour levels (CL). 
The experiments were repeated at 45 °C but no significant changes were noticed. 
The 1 D 1 H proton signals seemed a little more dispersed but still weaker. The 2D HSQC 
spectrum continued to show more and weaker peaks. Change in pH of the sample also did 
not produce any significant alteration in spectral features. 
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The most likely explanation for the reduction in peak intensity is that the peptide 
induced aggregation of the DPC micelles resulting in large complexes. The intensities 
reduced because the resonance linewidths were broadened as a consequence of more 
efficient transverse relaxation caused by the large complexes. The extra peaks in 2D 
HSQC indicated that multiple conformations of the peptide were present in DPC 
environment. 
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Figure 3.1 : 1 D 1H spectrum of SP-BcrERM in DPC micelles. All the regions including that for the 
backbone amide protons(- 6.5-8.5 ppm) show much less dispersion of chemical shift signals in 
comparison with what were observed earlier by Booth et a/. in HFIP and SDS (shown in the 
insets). The intensity of the signals in DPC are also weaker than that in HFIP and SDS as shown 
by the corresponding numbers. 
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3.4 NMR Spectra of SP-BcTERM in LPG Micelles 
Next, the conformational and micelle-binding features of SP-BcTERM were studied 
in micelles formed by the anionic lipid LPG (a single chain analog ofPG). The pH of the 
sample was set at 4.5 and the initial experiments were performed at 25 °C. 
The 1D 1H spectrum ofSP-BcTERM in LPG is shown in Figure 3.3. Similar spectra 
obtained earlier by Booth et al. for the peptide in HFIP and SDS are shown in the insets. 
Comparison of the backbone HN regions ( ~ 6.5 - 8.5 ppm) indicate that the spectrum of 
SP-BcTERM in LPG showed only a few very weak resonance signals that were almost lost 
in the noise. Signals were too weak to comment on dispersion. The numbers 
corresponding to the intensities of the highest signals in HN regions, normalized by the 
number of scans, show that the intensity of the signal in DPC is over 72 times weaker 
than that in HFIP and about 52 times weaker than that in SDS. 
The 2D 15N_IH HSQC spectra of SP-BcTERM obtained in LPG is shown in Figure 
3.4. Similar spectra obtained earlier by Booth et al. for the peptide in HFIP and SDS are 
also shown. The spectra in HFIP and SDS showed the expected six peaks corresponding 
to the six 15N-labeled amino acids. However, the spectrum in DPC showed three weak 
peaks and several very weak peaks. The peaks in LPG were weaker by factors of about 
100 and 10, respectively, than what were observed in HFIP and SDS, as shown by the 
numbers representing the contour levels (CL). 
The experiments were repeated at 45 °C. Almost no change was noticed in the 1D 
spectrum. The 2D HSQC spectrum showed somewhat six peaks this time but those were 
still very weak. Change in pH also did not produce significant changes in spectral 
features. 
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The reduction in peak intensity, again, was likely due to the peptide induced 
aggregation of the LPG micelles forming large complexes. Reduction of the peak 
intensity resulted from the broadenning of the resonance linewidths due to more efficient 
transverse relaxation caused by the large complexes. The less number of peaks with 
similar intensity indicate that the petide didnot have proper secondary folding either. 
Several very weak peaks in 2D HSQC indicate that the peptide took multiple 
conformations as well. 
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Figure 3.3 : 1 D 1H spectrum of SP-BcTERM in LPG micelles. All the regions including that for the 
backbone amide protons (- 6.5 - 8.5 ppm) show very little signals. Similar spectra obtained in 
HFIP and SDS (shown in the insets) obtained earlier by Booth eta/. showed good disersion. The 
intensity of the signals in LPG were also much weeker than that observed in HFIP and SDS as 
shown by the corresponding numbers. 
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3.5 NMR Spectra of SP-BcTERM in LP A Micelles 
The cationic protein SP-B has been suggested to bind to the anionic phospholipids 
of the native surfactant [16]. Hence NMR studies were continued to investigate the 
conformational and micelle-binding features of SP-BcTERM in another micelle system 
formed by the lipid LP A. This lipid possesses a single acyl chain and an amomc 
headgroup. The sample had pH of 3.3 and the data were acquired at 25 °C. 
The 1D 1H spectrum ofSP-BcTERM in LPA is shown in Figure 3.5. Similar spectra 
obtained earlier by Booth et al. for the peptide in HFIP and SDS are shown in the insets. 
The backbone HN region ( ~ 6.5 - 8.5 ppm) of the spectrum in LP A showed only a few 
peaks with very poor intensity and very little dispersion. Comparison with the spectra in 
HFIP and SDS, considering the intensities of the highest signals in HN regions 
normalized by the number of scans, showed that the intensity of the signal in LP A is over 
21 times weaker than that in HFIP and over 15 times weaker than that in SDS. 
The 2D 15N_lH HSQC spectra of SP-BcTERM obtained in LPA is shown in Figure 
3.6. Similar spectra obtained earlier by Booth et al. for the peptide in HFIP and SDS are 
also shown. The peptide had six 15N-labeled amino acids. The spectra in HFIP and SDS 
showed the expected six peaks corresponding to those amino acids. However, the 
spectrum in LP A showed no peaks at all indicating that the intensity of the peptide 
signals were similar or smaller than that of the noise. 
The most likely explanation for the reduction of intensity of the 1 D 1 H signals, 
again, is that the peptide induced aggregation of the LP A micelles producing complexes 
bigger than the NMR accessible sizes. However, no comments on the folding or 
conformational homogeiniety can be made due to the absence of any peaks in the 2D 
HSQC spectrum. 
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Figure 3.5 : 1 D 1H spectrum of SP-BcrERM in LPA micelles. All the regions including that for the 
backbone amide protons (- 6.5- 8.5 ppm) show only a few very weak chemical shift signals in 
comparison with what were obtained earlier by Booth et a/. in HFIP and SDS (shown in the 
insets). The intensity of the signals in LPG are much weaker than that in HFIP and SDS as shown 
by the corresponding numbers. 
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3.6 NMR Spectra of SP-BcTERM in DHPC Micelles 
Lastly, the conformational and micelle-binding features of SP-BcrERM were 
investigated in micelles formed by another zwitterionic lipid DHPC (an analog of PC). 
This lipid contains two acyl chains but those are short enough so that it can form micelles 
in water and can be used for protein NMR studies. The pH of the sample was 3.3 and the 
data were recorded at 25 °C. 
The lD 1H spectrum ofSP-BcrERM in LPA is shown in Figure 3.7. Similar spectra 
obtained earlier by Booth et al. for the peptide in HFIP and SDS are shown in the insets. 
As seen from the backbone HN regions (~ 6.5 - 8.5 ppm), the spectrum in DHPC 
exhibited a better dispersion of proton resonance signals in comparison with that of the 
previous three lipid micelles systems (Figure 3.11). However, the signals in DHPC were 
still weaker than that in HFIP and SDS. The intensities of the highest signals in HN 
regions, normalized by the number of scans, showed that the intensity of the signal in 
DHPC is over 6 times weaker than that in HFIP and over 4 times weaker than that in SDS. 
The 2D 15N-1H HSQC spectra of SP-BcrERM obtained in DHPC is shown in 
Figure 3.8. Similar spectra obtained earlier by Booth et al. for the peptide in HFIP and 
SDS are also shown. The spectra in DHPC, unlike that for the other three micelle systems, 
showed six distinct peaks corresponding to the six 15N-labeled amino acids although two 
of them were almost overlapped. However, the peaks in DHPC were weaker by factors of 
25 and 2.5, respectively, than what were observed in HFIP and SDS, as shown by the 
numbers representing the contour levels (CL). 
Some reduction of the intensity of signals in DHPC was seen in comparison to 
that in HFIP and DPC. It is, therefore, possible that the peptide induced aggregation of 
the micelles but the complexes were still within the NMR accessible sizes. However, 
SP-BcrERM folded into a specific secondary structure and did not take multiple 
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conformations in DHPC environment, as indicated by the spectral features of the lD 1H 
and 2D HSQC spectrum. 
SP-B~TE~ 1i~ SDS 
I I I 
IntenSity 
~~~:~~~~ ~" 
• • ~ t t • 
, ... 
11 10 9 B 7 
-
6 5 4 3 2 0 -1 -2 
Hppm 
Figure 3.7 : 1 D 1H spectrum of SP-BcreRM in DH PC micelles. All the regions including that for the 
backbone amide protons(- 6.5- 8.5 ppm) show reasonable dispersion of chemical shift signals. 
However, the intensity of the signals was weaker than that observed earlier by Booth et a/. in 
HFIP and SDS (shown in the insets). 
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3.7 CD Spectra of SP-BcTERM in DPC and LPG Micelles 
The NMR results for SP-BcTERM in DPC and LPG micelles indicated peptide-
induced aggregation of micelles. Since SP-BcTERM had been proposed to form 13-sheet 
aggregates, circular dichroism (CD) was used to assess the nature of the secondary 
structure of the peptide within the aggregated complexes. Unlike the solution NMR, CD 
can indicate the secondary structure, even in the aggregated samples. 
Circular dichroism is a technique that employs polarised light. The basis of CD is 
the differential absorption of two kinds of circularly polarised light, right (electric field 
having a clockwise spiral) and left (anti-clockwise spiral), by a chiral chromophore (such 
as a protein). A molecule which can not be superimposed on its mirror image is known as 
chiral and the chemical group that gives color to a molecule is called chromophore. When 
a sample containing a chiral chromophore is illuminated by a beam comprising the two 
kinds of circularly polarised light, the amplitude of the electric field vector of one is 
reduced compared to the other and the transmitted light traces an elliptical path as it 
moves forward. 
The backbone of a protein/peptide shows different optical activity depending 
upon wheather it is in helical (a) or extended (13) type configuration. Therefore, CD can 
provide some information about the secondary structure. a-helical peptide bonds yield 
two negative peaks (minima) at around 208 and 222 nm and a positive peak (maximum) 
at around 190 nm. The 13-sheet conformation is characterised by a minimum at 216 nm 
and a maximum around 195 nm. However, the spectral extremes of disordered 
polypeptides are similar to those of 13-structure and can thus interfere. For this reason CD 
is considered to work better for detecting a-type structures than 13-type. 
Both of the CD spectra obtained for SP-BcTERM in DPC and LPG micelles showed 
two minima at around 208 and 222 nm and one maximum close to 190 nm (Figures 3.9 
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and 3.1 0) which were indicative of perfectly a-helical structure of the peptide. Hence, 
despite of inducing aggregation, the peptide remained largely a-helical and did not take 
on 13-sheet or unstructured conformations. However, the NMR samples were diluted by 
about 1000 times to obtain the CD spectra. Since, the secondary structure of a peptide 
CD[mdeg] 
CD[mdeg] 
200 210 '2.110 250 260 270 280 290 
Wavele!fgth[nm] 
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Figure 3.9 : Far-
UV CD spectrum 
of SP-BcrERM in 
DPC micelles. 
[Peptide concen-
tration - 5 f.tm, 
light path 2 nm, 
number of 
accumulations 2, 
temperature 25 °C 
and pH 5.5]. The 
curve shows two 
minima close to 
208 nm and 222 
nm and one 
maximum close to 
190 nm. These are 
characteristics of 
300 a-helical peptide. 
Figure 3.10: Far-
UV CD spectrum 
of SP-BcrERM in 
LPG micelles. 
[Peptide concen-
tration - 25 ~-tm, 
light path 2 nm, 
number of 
accumulations 2, 
temperature 25 °C 
and pH 4.5]. The 
curve shows two 
minima close to 
208 nm and 222 
nm and one 
maximum close to 
190 nm. These are 
characteristics of 
300 a-helical peptide. 
depends on concentration also, it could not be concluded without doubt that SP-BcTERM 
had uniform single helical conformations in the original NMR samples in DPC and LPG. 
3.8 Dynamic Light Scattering of SP-BcTERM in DPC Micelles 
The NMR spectra of SP-BcTERM in DPC and LPG micelles indicated aggregation 
of lipid molecules induced by the peptide. The CD spectra, on the other hand, indicated 
that despite aggregation, the structure of the peptide itself remained largely a-helical. At 
this stage, in order to directly determine the sizes of SP-BcTERM-micelle aggregates in the 
DPC sample, dynamic light scattering (DLS) experiments were performed. This was 
done in collaboration with Qi Wang of Agriculture and Agri-Food Canada. 
DLS is one of the most popular methods used to determine the size of particles in 
solution. Shining a monochromatic light beam, such as a laser, onto a solution with 
spherical particles in Brownian motion, causes a Doppler shift when the light hits the 
moving particle. This is due to the change in wavelength of the incoming light. The 
change, however, is related to the size of the particle. It is thus possible to compute the 
sphere size distribution and give a description of the particle's motion in the medium, by 
measuring the diffusion coefficient of the particle and using the autocorrelation function. 
To determine the size of the peptide-micelles aggregates, DLS experiments were 
done with the original NMR sample, i.e., 1.5 mM SP-BcTERM, 150 mM DPC and 0.4 mM 
DSS, mixed in 90% H20 and 10% D20. For the purpose of comparison, data were also 
collected for a sample with 150 mM DPC but no peptide. 
The spectrum of the DPC-only sample showed a distribution of particle sizes 
(diameters) in three different regions (Figure 3.11); one at ~ 1.25 nm with relative 
intensity 33 which likely represented dust, one at~ 7 nm with relative intensity 54 which 
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represented micelles in NMR spectroscopic observation range and the other at ~ 440 nm 
with relative intensity 100 that represented aggregated lipids beyond the solution NMR 
observable range. 
The spectrum of DPC + SP-BcTERM sample showed more distribution of particle 
sizes (Figure 3.12). The first group of particles had diameters at ~ 1.33 nm with relative 
intensity 12 which again probably represented dust, the second group had diameters of 
~ 7 nm with relative intensity 3 that represented lipid-peptide complexes observable by 
NMR and the third group had distribution at ~ 420 nm with relative intensity 1 00 that 
represented aggregated micelles not observable by NMR because of the bigger size. 
There had been a fourth group of particles as well of diameters around 6000 nm and over 
with relative intensity 2 that were even further from the NMR observable range. 
The expected mmtmum s1ze of a single DPC micelle (i.e., without any 
aggregation) is 4 nm [Table 2.2] which is consistent with the population of particles 
observed at 5-7 nm. Particles much larger than this would not be expected to be 
observable in solution NMR spectra. Addition of SP-BcTERM to DPC had the effect of 
increasing the ratio of very large aggregates ( ~ 400 nm) to single micelles ( ~ 5 nm). In 
the presence of the peptide, there also appeared a greater range in the aggregate size as 
seen by~ 200-400 nm in DPC alone and~ 75-1800 nm in DPC + SP-BcTERM. In presence 
of the peptide, a small population of intermediate sized particles, ~ 20 nm, also appeared. 
The DLS findings imply that when only DPC was added to water, it formed 
micelles of different sizes, both suitable for NMR detection as well as bigger than that. 
However, when SP-BcTERM was mixed with DPC, NMR observable complexes were 
almost lost and mostly the bigger complexes were present with a much higher 
distribution range. This had been a clear indication of SP-BcTERM induced aggregation of 
DPC micelles which was predicted earlier from NMR results. 
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Figure 3.11 : DLS 
data of only D PC 
(150 mM DPC in 
90% HzO and 1 0% 
DzO). The particles 
with diameters - 1.25 
nm probably 
represent dusts. The 
particles with 
diameters- 7.61 nm 
represent micelles 
formed by DPC 
molecules that can 
be observed in NMR. 
The particles with 
diameters- 441.05 
nm also represent 
DPC micelles but are 
too big to be 
detected in NMR 
spectroscopy. 
Figure 3.12: DLS 
data of DPC + SP-
BcrERM (150 mM DPC 
and 1.5 mM SP-BcrERM 
in 90% H20 and 1 0% 
DzO). The particles 
with diameters - 1.33 
nm possibly represent 
dusts. The particles 
with diameters 5.62 
and 7.50 nm represent 
peptide-micelle 
complexes that are 
observable by NMR 
but the intensity is very 
low. The particles with 
diameters- 421.70 
nm represent bigger 
complexes that can 
not be detected by 
NMR although the 
intensity is very high. 
3.9 NMR Spectra ofRP-1 in DPC Micelles 
The ability to induce micellular aggregation of another amphiphilic and positively 
charged peptide, RP-1, was investigated to probe the uniqueness of this ability in 
SP-BcTERM. The DPC micelle system was used for this purpose. RP-1 is modeled on 
human proteins with antimicrobial activities called kinocidins. It is an 18 residue peptide 
with 8 positively charged amino acids. Its structure were determined in SDS micelles 
which showed that the peptide possesses an a-helical conformation. The conformational 
features of RP-1 were investigated further in DPC micelle system. The results were then 
compared to that of SP-BcTERM. 
The SDS sample ofRP-1 consisted of 1.5 mM peptide, 150 mM SDS and 0.4 mM 
DSS in 90% H20 and 10% D20. The sample had pH of 6.9 and the data were collected at 
different temperatures from 25 to 45 °C. The DPC sample of RP-1 was prepared with 
analogous conditions to the SP-BcTERM sample, i.e., 1.5 mM peptide, 150 mM DPC and 
0.4 mM DSS were mixed to 90% H20 and 10% D20. The pH of the sample was 6.8 and 
the experiments were done at 25 °C. 
The 1D 1H spectrum of RP-1 in DPC is shown in Figure 3.13. Similar spectra 
obtained for the peptide in SDS at 25 and 40 °C are shown in the insets. All the 1D 1H 
spectra showed reasonable dispersion of HN and Ha signals. The intensity of signals in 
DPC was also comparable to that in SDS. The 2D 15N-1H HSQC spectrum of RP-1 in 
DPC is shown in Figure 3.14. Similar spectra obtained for the peptide in SDS at 25 and 
40 °C are also shown. The peptide had five 15N-labeled amino acids. The spectrum in 
DPC showed the expected five peaks although two of them were almost overlapped. The 
intensity of the peaks were same for both SDS and DPC samples. These spectral features 
indicated that RP-1 took on a well-structured and homogeneous conformation in both the 
lipid systems without causing any significant micelle aggregation. 
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Comparison of the results for RP-1 and SP-BcTERM in DPC micelles draws clear 
conclusion that SP-BcTERM caused aggregation of the micelles while RP-1 did not. 
RP-11n sos at45 °C 
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•• J l • t t l D 
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Figure 3.13 : 10 'H spectrum of RP-1 in DPC micelles. All the regions including that for the 
backbone HN and H" regions show good dispersion of chemical shift signals. The dispersion is 
comparable to that obtained earlier for RP-1 in SDS micelles at 25 and 40 °C (shown in the 
insets). The intensity of the signals are comparable too as shown by the corresponding numbers. 
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3.10 Discussion 
Lung surfactant prevents alveolar collapse and eases the work of breathing by 
reducing the surface tension to extremely low values at air-water interface. SP-B is an 
essential component of the surfactant. Absence of SP-B is lethal in newborns [28]. Mice 
with the SP-B gene knocked-out also die early after birth [29]. The basis for SP-B's 
critical role is still not clear but it appears to originate somehow from SP-B's ability to 
reorganize lipid structures. Biophysical studies have yielded a long list of in vitro 
activities that may be important in SP-B's in vivo roles, including membrane binding, 
membrane lysis, membrane fusion, promotion of lipid adsorption to air-water surfaces, 
stabilization of monomolecular surface films and respreading of films from collapsed 
phases [36]. The studies presented here add additional insight by probing SP-B's ability 
to modulate the structures of highly curved lipid micelles. 
The amino acid distribution along the sequence of SP-B supports formation of 
several amphiphilic a-helical segments which are hydrophobic on one side and 
hydrophilic on the other [67]. This suggests a relatively superficial disposition of the 
protein in lipid bilayers and monolayers [16, 68] with the charged and polar amino acids 
interacting with the lipid headgroups and the hydrophobic amino acids interacting with 
the lipid acyl chains. SP-B contains nine positively charged amino acids, with a net 
charge of + 7. This gives the protein a cationic character that suggests a preferential 
interaction of the protein with anionic phospholipids, such as PG, both in bilayers [69] 
and monolayers [70]. In particular, selective interaction of SP-B with anionic 
phospholipids could be important for the formation of nonbilayer intermediates required 
in bilayer-monolayer transitions [71]. SP-B- PG interactions have also been proposed to 
promote enrichment of the interfacial films with the most surface-active phospholipids, 
during compression [16, 72]. SP-B also plays a critical role in the formation of SP-A-
DPPC tubular myelin structures that are important in transporting phospholipids from the 
aqueous subphase to the surface monolayer [73, 74]. All of these observations point to 
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SP-B's essential contributions in maintaining the molecular structure and continuity of 
the surfactant monolayer during breathing as well as facilitating the incorporation of 
phospholipids from aqueous subphase to air-water interface [42]. Large-scale 
rearrangement of phospholipids and stabilization of the structures by SP-B through 
binding underlie all these functions. Models have been proposed with several types of 
SP-B -lipid combined structures, with SP-B attached to monolayer, bilayer, in between 
monolayer and bilayer, within bilayer, inside curve, outside curve, in bilayer-break, etc. 
[16, 18]. Figure 3.15 shows the interactions ofSP-B and phospholipids. 
SP-B 
Phospholipids 
Figure 3.15: A model showing SP-B- phospholipids interactions in surfactant layers. 
As an active peptide segment of the full-length SP-B, the SP-BcTERM was 
expected to take on a-helical conformation and to exhibit ability of binding lipids 
analogous to the physiological phospholipids. The results from NMR studies and 
additional information obtained from CD and DLS experiments supported these 
hypotheses. SP-BcTERM clearly demonstrated its ability to facilitate large-scale lipid 
rearrangement through binding lipid micelles. 
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The lD 1H spectra of SP-BcTERM in all the four lipid micelle systems, composed 
from DPC, LPG, LPA and DHPC, showed significant reduction of resonance signal 
intensity in comparison with that in HFIP and SDS, studied earlier by Booth eta!. [42]. 
More reduction of intensity was noticed for the micelle systems formed by LP A and LPG. 
Moreover, the chemical shifts of the amide proton signals, which are usually the best 
resolved resonances in protein NMR, showed far less dispersion than expected with some 
exceptions for that in DHPC. In comparison with previously obtained spectra in HFIP 
and SDS, the 2D 15N-1H HSQC spectra ofSP-BcTERM also showed much weaker intensity 
of peaks in DPC and LPG. The peaks in LP A were even totally lost in the noise. Also, in 
DPC and LPG, the peptide exhibited multiple conformations indicated by more peaks 
than expected. In DHPC, the spectra showed six expected peaks but the signals were still 
weaker. These observations lead to the following conclusions regarding the 
conformational features of SP-BcTERM in DPC, LPG, LPA and DHPC and its ability to 
bind the micelles formed from these lipids. 
Firstly, the reduction of peak intensity in both lD and 2D spectra was a direct 
consequence of bigger peptide-lipid complexes caused by peptide induced aggregation of 
lipid micelles. In solution NMR, increasing the complex size leads to slower tumbling 
and hence more efficient relaxation. This, in turn, leads to broader and less-intense peaks 
in the NMR spectra. Comparison of the spectral features in four lipids showed that the 
intensity reduction was more prominent for LPA and LPG, the lipids containing anionic 
headgroups, than for DPC and DHPC, the other two lipids containing zwitterionic 
headgroups. Figure 3.16 shows SP-BcTERM and micelles drawn with appropriate relative 
size scaling and presents a model of how the peptide may initiate aggregation of micelles. 
The model is consistent with the charge distribution on SP-BcTERM shown in Figure 3.17. 
The peptide is capable of interacting with two or more lipid headgroups at each of its 
positively charged patches. These patches are distributed over the surface of SP-BcTERM 
in such a way that electrostatic interactions with lipids may occur on two nearly opposite 
faces of the peptide as well as at the positively charged end. While SP-BcTERM was most 
effective in inducing aggregation of anionic phospholipids, it also induced significant 
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Secondly, the lack of chemical shift dispersion in 1 D spectra and extra peaks in 
2D spectra indicated that the SP-BcTERM did not fold properly into a single 3D structure 
in DPC, LPG and LP A. The spectra indicated that the peptide took on multiple 
conformations possibly as required to bind the lipid micelles together from different 
positions (Figure 3.16B). This view is not contradictory with the observations from CD 
spectra in DPC and LPG, which demonstrated the structures of the peptide as mostly 
a-helical. The CD is only able to indicate if a structure is helical, not ifthere are multiple 
helical structures present. 
Thirdly, the NMR spectra indicated that SP-BcTERM induced aggregation of 
micelles with a variety of diameters. The diameters of the micelles are 4 nm for DPC, 5.6 
nm for LPG and 3.3 nm for DHPC (Table 2.2). As the number of lipids that form each 
micelle is known (except for LPA), the number of micelles per peptide can be calculated. 
It is 2.7 for DPC, 1.2 for LPG and 3.75 for DHPC. SP-BcTERM is thus able to induce 
aggregation of a variety of micelle/peptide ratios (Figure 3.16). 
To probe the uniqueness of the ability of SP-BcTERM in inducing aggregation of 
micelles, another cationic amphiphilic peptide with known helical structure, RP -1, was 
studied in DPC. The 1D 1H spectrum obtained for this peptide showed signals with 
intensity levels and chemical shift dispersion expected for a single helix conformation 
bound to a non-aggregated single micelle. The 2D 15N-1H HSQC spectrum showed the 
expected number of peaks corresponding to the 1 ~-labeled amino acids also with good 
intensity. Therefore, RP-1 took on a well-defined homogeneous conformation in DPC 
and did not produce any bigger peptide-micelle complexes. 
Hence, the same lipid system that underwent aggregation in the presence of 
SP-BcTERM, did not aggregate in the presence of RP-1. This further emphasized the 
uniqueness of SP-BcTERM's ability to induce aggregation of certain phospholipid micelles. 
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These studies show that a single helix from SP-B can induce aggregation of 
anionic, and to a lesser extent, zwitterionic phospholipids. This observation constrains the 
models of interactions of full-length SP-B with lipids presented in Figure 3.15. Since the 
single helix of SP-BcTERM retains about half the activity of full-length SP-B (Figure 1.4), 
interactions that require SP-B to cover a large distance (e.g., to traverse the bilayer) 
cannot be of utmost importance. These studies show that a single helix ofSP-B is capable 
of inducing strong interactions between regions of phospholipids with "outside" 
curvature- most similar to the interactions shown at the far left of Figure 3.15. The high 
degree of biological functionality of SP-BcTERM implies that these types of interactions 
are of high biological consequence when compared to myriad of lipid-binding activities 
that have been proposed for SP-B. 
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Chapter 4 
Structure of Mlni-B 
4.1 Overview of Structural Studies of Mini-B 
SP-B is essential for normal lung surfactant function but the molecular basis for 
its activity is not yet understood. This is because the 3D structure of this protein has not 
been determined so far. Theoretical models predicted that theN- and C-terminal domains 
of SP-B fold as charged amphiphilic (hydrophobic in one side and hydrophilic at the 
other) a-helices connected by disulfide bonds and suggested that these adjacent helices 
participate in critical surfactant activity [75]. The peptide fragment of SP-B containing 
these two terminal regions was termed as Mini-B. Mini-B in model surfactant lipid 
mixtures exhibited marked in vitro activity, similar to that observed with native SP-B. In 
vivo, too, Mini-B showed oxygenation and dynamic compliance that compared favorably 
with that of full-length SP-B. These studies concluded that the combination of structure 
and charged patches for the amphiphilic a-helical N- and C-terminal domains of SP-B 
(i.e., Mini-B) are key to its function [76]. However, to understand the mechanisms of 
function, a detailed 3D structure of Mini-B is essential. Hence, using solution NMR, the 
high-resolution structure of Mini-B was determined in structure-promoting organic 
solvent HFIP as the main part of present research. 
4.2 Materials and Methods 
Mini-B is a synthetic 34 residue peptide consisting of a fusion of residues 8-25 
and 63-78 ofhuman SP-B. Its amino acid sequence is shown below. 
Cys-Trp-Leu-Cys-Arg-Ala-Leu-Ile-Lys-Arg-Ile-Gln-Ala-Met-Ile-Pro-Lys-Gly-Gly-Arg-
1 5 10 15 20 
Met-Leu-Pro-Gln-Leu-Val-Cys-Arg-Leu-Val-Leu-Arg-Cys-Ser 
21 25 30 34 
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Mini-B was synthesized chemically by Alan Waring (UCLA) following the same 
procedure as for SP-BcTERM (Section 3.2) [42]. Nine of the residues, namely leucines 3, 7, 
22, 25, 29 and 31, alanines 6 and 13 and glycine 18 were 15N labeled, i.e., the natural 
isotope 14N at the backbone of these residues were replaced by spin 1/2 1~ nuclei. The 
peptide contains four cysteines but it was synthesized without any disulfide bonds 
between any pairs of cysteines. 
The NMR sample of Mini-B in fluorinated organic solvent was prepared by 
dissolving 1.5 mM peptide in 40% HFIP, 50% HzO and 10% DzO with 0.4 mM DSS. The 
peptide was weighed out in dry form assuming it was 1 00% pure. HFIP (> 99% 
deuterated), DSS and DzO were purchased from Cambridge Isotope Laboratories, Inc. 
(Andover, MA). DSS was used to obtain the proton reference signal at 0 ppm and D20 
was used to provide the lock nucleus (deuterium) to the field-frequency lock system of 
the spectrometer. The volume of the sample was 500 ~-tL. To avoid any undesired folding 
of the peptide resulting from disulfide bonds between cysteines (both intra- and inter-
chain), the pH of the sample was set at 5. The pH was measured by an accumet Electrode 
bought from Fisher Scientific. 
Initial 1D 1H and 2D 15N_IH HSQC experiments were done at three different 
temperatures (15, 25 and 35 °C) to evaluate the temperature dependence of the peptide 
conformation. It was observed that the peptide exhibited improved conformational 
homogeneity at 15 °C. Therefore, all subsequent complex multidimensional NMR 
experiments were conducted at 15 °C. The experiments included two 2D TOCSY (with 
mixing times of 45 and 80 ms), three 2D NOESY (with mixing times of 100, 200 and 300 
ms) and one 3D 15N-edited NOESY (with mixing time of 200 ms). Lastly, two additional 
2D TOCSY and NOESY experiments (with mixing times of 80 and 200 ms, respectively) 
were performed with a freshly prepared sample ofMini-B in 40% HFIP and 60% DzO by 
lyophilizing the peptide from the previous sample. 
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The NMR data acquisition began on Bruker A vance 500 MHz spectrometer of the 
Centre for Chemical Analysis, Research and Training (C-CART) at Memorial University 
of Newfoundland (MUN). However, during the initial acquirements of 1D 1H and 2D 
15N)H HSQC data, the RF probe of the spectrometer failed. While the probe was being 
repaired, the 1D 1H and 2D HSQC, TOCSY and NOESY spectra were collected using a 
Broker A vance 700 MHz spectrometer of Health Canada, Ottawa. The sample was 
returned to MUN for acquisition of the 3D NOESY and the last 2D TOCSY and NOESY 
(with lyophilized Mini-B in HFIP/D20) spectra. Both of the spectrometers used were 
equipped with z-gradients and triple-resonance TXI probes. The 1D 1H used presaturation, 
HSQC used flip-back and TOCSY-NOESY used water-gate water suppression 
techniques. 
The spectra were processed using the software NMRPipe 2.2 [66]. Frequency 
assignments for all the observable spin 1/2 nuclei of Mini-B were made using Sparky 
3 .11 0 [77]. Structures of the peptide were calculated using the simulated annealing 
algorithm within CNS 1.1 [78]. After each round of calculation, structures were viewed 
by MOLMOL 2k.2 [79]. At the end of the final round of calculation, an ensemble of the 
15 lowest energy structures of Mini-B was retained for analysis. This ensemble of 
structures has also been deposited in the Protein Data Bank (PDB) [PDB ID 2A2H]. 
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4.3 1H and HSQC Spectra 
Three 1D 1H and 2D 15N_IH HSQC spectra were collected at 15, 25 and 35 °C to 
optimize the temperature conditions for further spectral acquisition. 15 °C was chosen as 
the optimum temperature as it showed the best HN dispersion and the least 
conformational heterogeneity. Later on, lD 1H and 2D 15N_IH HSQC experiments were 
always performed routinely before and after any complex multidimensional NMR 
experiments to monitor for any changes in the sample. Spectra obtained thereby always 
showed identical response of signals indicating that the peptide conformation remained 
stable over time. 
Figure 4.1 shows a 1D 1H spectrum of Mini-Bat 15 °C. Well-dispersed signals 
with good intensity are seen which indicate that the protein was folded into a well-
defined 3D structure under these conditions. Figure 4.2 shows a 4D 15N_IH HSQC 
spectrum of the peptide at 15 °C. The peptide had a total of nine 15N labeled residues and 
the expected nine peaks corresponding to the covalently bonded 15N- 1H pairs of nuclei 
are seen here. Absence of any extra peaks indicates that Mini-B took on a single 
conformation in HFIP. However, the peaks for A13 and L25 are almost overlapped. Note 
that the 15N frequency of G 18 is 107 ppm. Here it appears at 126 ppm due to spectral 
aliasing since, to optimize the resolution, the spectrum was acquired with a reduced 
spectral width of 114 to 128 ppm. 
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Figure 4.1: 10 1H spectrum ofMini-8 in HFIP at 15 °C. The signals correspond to 
the resonance frequencies (chemical shifts) of the protons in the peptide. The amide 
protons show good dispersion of signals at- 7.2-8.6 ppm. 
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Figure 4.2: 20 15N-1H HSQC spectrum of Mini-Bin HFIP at 15 °C. The peptide has 
nine 15N-Iabeled amino acids. Nine peaks relating the resonance frequencies of 
covalently bonded 15N- 1H pairs of nuclei in those amino acides are seen. 
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4.4 TOCSY and NOESY Spectra 
Two 2D TOCSY experiments were performed, with mixing times of 45 and 80 
ms, respectively. The spectrum obtained for 45 ms mixing time is shown in Figure 4.3. 
The off-diagonal cross peaks in the spectrum resulted from the through-bond 
magnetization transfer between scalar-coupled proton pairs (up to 3 bonds). 
Three 2D NOESY experiments were performed with mixing times 100 ms, 200 
ms and 300 ms, respectively. The spectrum acquired for 200 ms mixing time is shown in 
Figure 4.4. The off-diagonal cross-peaks seen here resulted from the through-space 
magnetization transfer between dipolar-coupled proton-pairs close in space (up to 5 A). 
The higher the mixing time, the greater the magnetization transfer between the 
proton pairs and the more intense the observed signals in NOESY. However, longer 
mixing times may allow spin diffusion, when magnetization transfer occurs through a 
third nucleus. This creates a problem for quantification of the NOEs for structure 
calculation. Therefore, though all3 NOESY spectra were used for resonance assignment, 
only the 200 ms spectrum was used to generate restraints for structure calculation. 
The 3D 15N-edited NOESY experiment was done with the mixing time of200 ms. 
This spectrum only exhibited NOEs to protons attached to 15N-labeled residues and 
separated the 2D 1H-1H spectrum by a third dimension (the 15N frequency). The resulting 
spectral simplification resolved some of the overlapped peaks of the 2D NOESY. 
After all other experiments were done, the sample was lyophilized and the peptide 
powder was dissolved in 40% HFIP and 60% D20. 2D TOCSY and 2D NOESY 
experiments were performed with this freshly prepared new sample with mixing times of 
80 and 200 ms, respectively. These two experiments were conducted to check out the 
presence of any strong H-bonds (i.e., - N - H --- 0 = C -, between residues) in the 
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peptide and assign the ring protons of tryptophan. The spectrum of the 2D NOESY is 
shown in Figure 4.5. Because the amide protons were labile, they were rapidly exchanged 
with the deuterons and the NOEs that correlated them were lost immediately. Absence of 
the NOEs implied that Mini-B did not have any strong H-bonds between residues. The 
quick exchange of amide protons with deuterons was confirmed by a lD 1H experiment 
done within 2 minutes of adding D20 followed by a 2D 15N-1H HSQC experiment and 
observing no peaks in the spectra corresponding to the amide protons. 
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Figure 4.3 : 20 TOCSY spectrum of Mini-B in HFIP with mixing time of 45 ms. The diagonal 
peaks correspond to the complete 1 D 1H spectrum. The off-diagonal cross-peaks represent the 
correlation resulted from the magnetization transfer between covalently bonded HN and Ha and 
then around the side chain in each of the amino acids. 
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Figure 4.4 : 20 NOESY spectrum of Mini-8 in HFIP with mixing time of 200 ms. The diagonal 
peaks correspond to the complete 1 D 1H spectrum. The off-diagonal cross-peaks represent the 
correlation resulted from the magnetization transfer between proton-pairs that are close in space 
(less than 5 A). 
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Figure 4.5 : 20 NOESY spectrum of Mini-S in 40% HFIP and 60% 0 20. The amide protons 
were rapidly exchanged with the deuterons and the peaks correlating them are lost. 
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4.5 Resonance Assignment 
For NMR structural studies, each nuclear magnetic resonance needs to be 
associated with a specific nucleus in the molecule under investigation [45]. Resonance 
assignments also have to be sequence-specific, i.e., each resonance must be assigned to a 
spin in a particular amino acid in the protein sequence. For Mini-B, three types of 
information were collected from the NMR experiments for the purpose of spectral 
assignments : through-bond interactions (via scalar coupling, from TOCSY), through-
space interactions (via dipolar coupling, from NOESY) and chemical environment (via 
the chemical shift). Initially, the 1H resonances were categorized on the basis of their 
chemical shifts. 
The backbone amide protons ctHN) typically resonate between 10.0 and 7.0 ppm, 
the backbone a-protons ctHa.) resonate between 6.0 and 3.5 ppm, the aliphatic side-chain 
protons resonate between 3.5 and 1.0 ppm and the methyl protons resonate at chemical 
shifts less than 1.5 ppm [ 45]. Assignment of individual NMR resonances to individual 
nuclei in Mini-B started with the backbone amide protons which constituted the best 
resolved set of resonances. The alpha and side-chain resonances were correlated to the 
backbone amide protons in TOCSY by the observation of direct or relayed cross-peaks. 
The Ha.-HN region of the TOCSY spectrum of 45 ms mixing time is shown in Figure 4.6 
with the full assignment of the peaks as determined by the procedure discussed below. 
The 1Ha.-HN cross-peak is missing as usually theN-terminal amide proton is not observed 
in TOCSY. Overlapping of peaks is seen in two cases, one for K17 and R28 and the other 
for R20 and L31. 
In NOESY spectra, spin systems were assigned first to particular residues by 
usmg through-space dipolar interactions to sequentially connect the spin systems 
identified from through-bond scalar correlations. Next, the connections between inter-
residue protons with sufficient proximity were identified. The majority of short 
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interproton distances between 1HN, 1Ha and 1H11 of an a-helical protein/peptide are 
between residues adjacent in the primary sequence [80]. Thus, identification of intense 
NOEs from 1HN, 1Ha and/or 1H11 of one spin system to 
1HN of a second spin system 
indicated that the two spin systems are adjacent in the primary sequence, with the first 
one nearer to theN-terminus. Identification of a series of sequential NOEs placed several 
spin systems in order and as more spin systems were connected, the sequence eventually 
matched the primary amino acid sequence of the peptide. The observation of NOEs was 
not limited only to sequential interactions, since a substantial number of NOEs occurred 
between nonsequential residues as a result of the secondary structure of the peptide. 
Those were identified as medium-range NOEs and resulted from proton-pairs from up to 
five residues apart in the primary chain. 
Figures 4.7 and 4.8 show the Ha-HN and HwHN regions of the NOESY spectrum 
acquired with mixing time of 200 ms with the full assignment of the peaks. The other 
portions of the spectrum are shown in Figure 4.9. These spectra showed ambiguity of 
resonance assignments in many cases, in addition to overlapping of peaks. The ambiguity 
in assignment occurred when a particular NOE exhibited correlation that might have 
resulted from more than one pair of inter-residue protons. 
The 3D 15N-edited NOESY helped substantially in resolving the overlapped peaks 
correlated with the residues adjacent to the nine 15N-labeled amino acids. This 
experiment enabled resolution of the ambiguous protons by generating slices edited by 
the chemical shifts of the 15N nuclei bounded directly to the 1H spins. Notably, the 
resonance assignments for K17, which preceded 15N-labeled G18, were primarily made 
with the help of this experiment, since the protons of K17 were almost fully overlapped 
with those of R28 in the 2D homonuclear TOCSY and NOESY. Figure 4.10 shows all the 
assigned slices of the 3D 15N-edited NOESY. 
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The majority of the peaks in the NOESY spectrum were assigned with proton 
resonance frequencies. The remaining unassigned peaks likely originated from peptide 
impurities or protonated HFIP. A total of 797 NOEs were assigned, out of which 760 
were unambiguous while the rest 37 were ambiguous. Ambiguous NOEs were assigned 
in cases for which up to four different inter-residue assignment possibilities existed. From 
these assignments, resonance frequencies (and hence the chemical shifts) were obtained 
for all the magnetic (spin 112) nuclei (i.e., 1H and 15N) expected to be observable. Table 
4.1 lists the chemical shifts of these nuclei that were identified following the assignments. 
The few protons left did not produce any observable NOEs and often they remain 
unassigned in NMR studies. Many of the missing assignments were at the side-chain ends 
and those neither interact significantly with the rest of the proteins nor possess many 
N 0 Es. The chemical shifts of protons at a particular position in the side-chain (e. g., (3, y, 
etc.) for which assignments could not be made stereospecifically are shown in red and 
those exhibiting degeneracy are shown in blue. 
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Figure 4.6 : Ha-HN region of 2D TOCSY spectrum (45 ms mixing time) of Mini-B. The peaks 
resulted from the correlation (magnetization transfer) between the intra-residue amide and alpha 
protons and are shown as .... HA-HN. All the 34 residues yielded signals except the N-terminal 
one (C1). This is because, usually theN-terminal amide proton response is not seen in TOCSY. 
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Figure 4.9 (cont.) : Additional regions of 20 NOESY spectrum (200 ms mixing time) of Mini-B. 
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Figure 4.10 : Assigned slices of 3D 15N-edited NOESY of Mini-B. NOEs only from the proton-pairs that were dipolar-coupled to 
the nine 15N nuclei were retained in the experiment. Peaks for G18 were folded to - 119.5 ppm to reduce the spectral width. 
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4.6 Structure Calculations 
Three-dimensional structures of Mini-B were calculated by dynamic simulated 
annealing. As explained in Section 4.4, after completing the spectral assignments of the 
three NOESYs using Sparky 3.110 [77], the spectrum with 200 ms mixing time was 
selected for generating the restraints to be used in the structure calculation. All the 
assigned NOEs were classified into strong, medium and weak categories depending on 
the peak intensities (heights). Proton-pairs were assigned a distance range according to 
which of the categories they fell in. A second list of restraints was generated from the 
hydrogen bonds between residues that were known to be within a-helical regions of the 
peptide. This was based on the preliminary data about the conformational mapping of 
Mini-B obtained by Alonso et al. using Fourier Transform Infrared (FTIR) Spectroscopy 
(PDB ID 1 SSZ) [81] and confirmed using local NOE patterns. A third list of restraints 
was generated from the allowed values of backbone dihedral angles corresponding to the 
known secondary structure. Table 4.2 summarizes the experimental restraints used in 
structure calculation. 
Table 4.2 : Experimental restraints for Mini-S structure calculation 
Distance restraints corresponding to the sequential and medium-range NOEs, 
backbone dihedral angle restraints and hydrogen-bond restraints constituted the required 
additional input files for Mini-B structure calculation using the simulated annealing 
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algorithm within CNS 1.1 [78]. Although most of the NOEs (559 out of 797) were intra-
residue, those were not added into the CNS input as they contribute little structural 
information but their inclusion tends to over-constrain the structure calculations. 
A total of nine rounds of structure calculations for Mini-B were performed in 
CNS. A total of 100 lowest energy structures were determined in each round from the 
first to the eighth and 200 in the final round. The first round began without the 
ambiguous NOEs and the resonances were also not stereospecifically assigned. The 
calculated structures were viewed by MOLMOL 2k.2 [79]. Some stereospecific 
assignments followed from the observation and some corrections in the distances 
assigned to restraints were made as well. Then the second round of calculation was 
performed and the structures were re-viewed. This enabled the making of more 
stereospecific assignments and helped again to correct more distance restraints. This 
process continued up to the fourth round. The ambiguous NOEs were then added and the 
fifth round of calculation was carried out. Additional NOE information obtained from the 
3D 15N-edited NOESY were incorporated in the sixth round. Three additional rounds of 
structures were calculated and, each time, subtle adjustments to the distances assigned to 
the restraints were made. After the final round, the lowest-energy 15 structures were 
retained for analysis. In this set, all the experimentally derived restraints were fulfilled, 
except for one minor NOE violation. The coordinates of these 15 lowest energy structures 
ofMini-B have been deposited in the Protein DataBank (PDB) [PDB ID 2A2H]. 
An important set of secondary structure indicators that came from the selected 
distance restraints is summarized in Figure 4.11. The height of the bars is proportional to 
the spatial proximity of the protons in pairs i.e., higher bars correspond to pairs of protons 
that are relatively close together. The resonance frequencies themselves also provided 
indications for the 3D structure. The chemical shift index (CSI) for the Ha resonances, 
which was obtained by subtracting the chemical shifts of Ha for residues in random coil 
configuration [82] from that ofMini-B, is shown at the bottom of Figure 4.11. CSI values 
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close to zero are indicative of a random coil configuration while significantly positive 
values of a helical (a-type) and significantly negative values of an extended (~-strand) 
conformations. These analyses confirmed that Mini-B consists of two helices, the first 
one runs through amino acids 2 to 14 while the second one stretches from amino acids 23 
to 3 3 in the chain. 
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Figure 4.11 : Structure indicators for Mini-B in HFIP. Selected distance restraints are shown at 
the top. The height of the bars correspond to the intensity of the NOEs. Strong NOEs (i.e., higher 
bars) for HNi-HNi+1 and Hai-HNi+1 proton-pairs are indicative of a-helical conformation. 
Prevalence of NOEs from the other proton-pairs shown here are also indicative of a-helical 
conformation. The chemical shift index (CSI) for the Ha resonances are shown at the bottom. This 
curve is obtained by subtracting the random coil Ha chemical shifts [82] from that of Mini-B. CSI 
values considerably lower than zero indicates helical conformation and that considerably higher 
than zero indicates extended conformation. These indicators suggest that Mini-B consists of two 
terminal a-helical regions connected by an unstructured loop at the middle. 
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The Ramachandran plot (a graph generated for the allowed values of dihedral 
angles <1> and '4') for the lowest energy structure ofMini-B is shown in Figure 4.12. All the 
residues found to form the helices in the structure are seen within the allowed regions for 
a-helix in the plot with most of them in the most favored region. 
120 
15 22 
20 
60 
0 
-60 
18 IV 
-120 
-180 
-180 -60 0 60 120 ¢ 180 -120 
Figure 4.12 : Ramachandran plot for the lowest energy structure of Mini-Bin HFIP. Code for the 
regions for a-helical structure : I - most favored, II - less favored, Ill - allowed and IV - not 
allowed. Residues are represented by the numbers representing their positions in the sequence. 
Most of the residues forming the two terminal helices according to the structure are seen within 
the most favored region. The rest of the helix-forming residues are also seen within the less 
favored and allowed regions. Residues in the middle portion are seen in the not allowed region. 
The terminal residues are missing as one of the two angles for them is not defined. 
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4.7 Structure of Mini-Bin HFIP 
The high resolution structure of Mini~B in aqueous solvent containing HFJP was 
found to consist of two well-defmed a-helical tenninal regions connected by an 
unstructured loop at the middle. Figure 4.13 shows a ball-stick structure of Mini-S that 
represents the lowest energy conformation from the 200 structures calculated in the la1i.t 
round. The atoms are shown as balls (the color code is explained in the figure caption) 
and the bonds bet\\reen the atoms are shown as sticks. 
Figure • .13 :The lowest enecgy ball·stick structure of M1ni-B in HFIP. Color code for atoms : C-
black, N - blue, 0- red, S- and H - gray. The tenninal regions ate seen to be a-h&Jical. 
Figure 4.14 shows the electrostatic surface charge plots for the lowest energy 
structure of Mini-B. The positively charged surface is shown in blue and the negatively 
charged surface in red. Mini-S carries a net charge of+ 7 (same as the full-length SP-8) 
at neutral pH and five of the seven positively charged residues are disuibuted at the 
tenninal a -helical regions. This makes the helices electrostatically biased. Models aimed 
to explain the functional characteristics of the native SP-B depict these cationic properties 
of the two tcnninal regions crucial for the interactions between the protein and the 
anionic phospholipids in the lung surfactant. It is the combination of structure and charge 
for thea-helical N-and C-tenninal domains that is the key to SP-B's function (76). 
Figure 4. 15 shows the relative pOSitions of the helix-forming residues of Mini·B 
plotted on helical wheels. For the first helix, 8 of the 13 residues are nonpOlar and mostly 
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po>~lloned 111he right pill of the wbcx:l. The 3 po51ti,ely chatacd ~dues are localized at 
the top. For the second helix. 5 out of II n:siducs ""' nonpolar and mostly localilt:d at 
the left half of the "heel. The 2 posili,-.:ly chaz&cd ruiducs are p<Xitioned at the bonom. 
Altbou&h Mini·B is dominated by nonpolar n:siducs and the h}drophobic ll8l\ft of the 
peplide i> lhlli obvious, the helical domains pcmess amplliphilic properties as well 
because of the presence of a few polar and cllar!lcd ruidues. 
Flgu,. 4.14 : EleclrOOialoc suliace charge plots for llleloweole-oy otructure of Mlni-B on HFIP. 
Colo< codo blue - posrl!vely cl\alged surface and rOd - negoti~ charged suliace. M.,..B 
cont.lna seven pos1trvely ctlarged residues which are mosUy dl1tt1buted In the termin~tl reg;on$ 
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An cn~~emble of the 15 lowest energy SlnlelurtS of Mini-B that was deposited to 
the PDB is sho"" in Figure 4.16. The backbone (gray) and the heavy atoms in the side-
chains (colored) are shown while the hydrogens arc omitted for clarity in Figure 4. 16 (A). 
It is noted that the middle segment that joins the two terminal helices is unstructured. 
Thus tho relative orientation of the two helices is not defined and the angle between the 
helices <ho"'l1 here is arbitrary. The backbone ribbon reprcsentatiOI\ of these 15 lowest 
encri)' structur., of Mini·B is shown in Figure 4.16 (B). Again. the 1\<0 termini of the 
peptide ore clearly seen to consist of two a-helices connected by a randomly oriented 
middle rcaion 
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Arg&Lys - Hydrophilic • ~ q q Hydrophobic 
Figure 4.16: All ensemb'-! of 151owest energy structures of Min~B in HFIP. (A) The backbone (gray) and the side·chain heavy atoms 
(colored) are seen while the side-chain hydrogens are omitted for clarity. (8) The backbone ribbon structures. The peptide Is clearly seen 
10 consl:st of two terminal a-heltees which are connected by an unstructured loop. The angle between the helices shown here is arbitrary 
as lhe relative orientation of the two helices is noC defined. 
4.8 Discussion 
It is a fundamental axiom of biology that the function of a protein depends on its 
3D structure [44]. Understanding function through structure is thus a primary goal of 
structural biology. However, the structure-function relationships of SP-B have not yet 
been established because the 3D structure of the native protein is still undetermined. 
Currently, researchers have attempted to characterize the peptide fragments of SP-B. The 
major emphasis of studying these peptides is to identify minimal regions of the protein 
retaining the interfacial properties thought to be important for exogenous surfactant 
activity [41, 42, 83 - 87]. Mini-B is a fragment of human SP-B, exhibiting significant 
biological activity of the full-length protein [76]. The first detailed structural 
characterization of this peptide has been obtained in the present research using solution 
NMR. This high-resolution structure of Mini-B will help to identify the structural basis 
that underlies SP-B's mechanisms of function. 
The sequence of SP-B is homologous to some other proteins, all of which belong 
to the Saposin protein superfamily characterized by a high content of a-helical secondary 
structure [88]. All of them also possess six cysteine residues, the relative positions of 
which are highly conserved to form three intramolecular disulfide bridges [89]. However, 
SP-B contains one extra cysteine and the native form of SP-B is a homodimer stabilized 
by a disulfide bridge through the fifth of the seven cysteines [75]. The members from the 
Saposin superfamily whose structures have been determined so far are: Saposin B (PDB 
entry 1N69 [37]), Saposin C (PDB entry 1SN6 [38]), NK-Lysin (PDB entry lNKL [39]) 
and Amoebapore (PDB entry 10F9 [40]). The structures of these proteins including 
Mini-B are shown in Figure 4.17. All the Saposin proteins contain four (or more) 
a-helices connected by loops. Table 4.3 lists the amino acid sequences of these proteins 
[88]. The helix forming residues are shown in red color and the disulfide bridge forming 
cysteines with gray shade in Table 4.3. The Mini-B residues of SP-B are shown 
underneath, with the two a-helices obtained from the structure determined in the present 
research in blue. 
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NMR slructural studies of membrane or lipid-associated proteinsipeptides are 
often attempted in organic solvent rather than in micelles. However. the organic solvent 
usually induces the secondary structure only, not the overall 30 conformation. The 
fluorinated alcohol (TFE) is a commonly used organic solvent to induce the secondary 
structure. HflP, although less commonly used in NMR studies, appears to be an even 
stronger secondary structure inducer. Presently, no widespread consensus has been 
reached on how these solvent systems promote the secondary structures. However. 
strengthening of both inlra·peptide hydrogen bonds and local hydrophobic interactions is 
likely to be important in TFE or HFlP stabilization of secondary structures [90, 91]. 
Tabkt 4.3 :Amino acid sequence of SP·B and other Saposin famiy members (88) 
Protein Amino acid sequence 
SP·B PPIPLP~1DlQAklftOA-----LAVA~n.Yr.-OOtiQa.aaltVJ.I.LDTLI.AiiiML.-PQJ.vilu.vt.Jis .... 
NKI.. O..YP~llQICUIDMVGfQn-I!:Dn7QAABO\II:tXL-It-li,AetlnlMJt$P&.U.liWPU.TGC•aPQAllvoilt··· 
Sap A SU-.,I~ar.OCINUU*A'I'·UUL~I'ItP ......... IVDatt.PVIl.OllltOII:MSa.acvla•ux.tLQ 
SapB ODViQoiiQICY70IQ'Z'AW.'IWT.TVg.U.VW:~PGMADlJutl.601611AlQMIIIOI--MQPI:Sl!IJI.LvoriD--1 
SapC aDVr~VUVftLJ!Iaft-aUIUIAI'D .. Q..PKS-L&IIIQcvwnGII:I:tAILLUVI•PSLvis~VPa 
SapO ~YQ'fLI)ItJIUDI'l'-ltQIILAAa.U..,..PDP·Io-~MUPVLIS~LW'YMD•PSrvltJttOAIPSU 
PFP 08l~IftLIIfLLTI'It•CJ-.APKVGli&&~-aGPu..nl'nvLof'O!OU.l-QLitoKVD.uw:..lu:Iul 
I Mini-B I -------~tnlQ»a JOtte----------.................................... --------.......... ---OIICL-f>OL•VLII:II-" 
As the main part of present research. the structure of Mini-B was detcnnincd. in 
organic solvent HFIP. Mini-8 was found to contain two Ct-helices al the terminal regions 
coJUlCCted by an unstructured loop. The amino acid distribution along the sequence of 
Mini·B (and also SP-8) supportS the formation of amphiphilic helical segments which are 
hydrophobic at one side and hydrophilic at the other. This set of motifs is common in 
other proteins of the Saposin superfamily and is implicated in the interaction of these 
proteins with lipids (75]. From the helical wheel diagrams (Figure 4.15). it is seen that the 
nonpolar residues of Mini-S are indeed mostly localized at one side of the helices making 
them amphiphilic. The arnphiphilicity of the helical segments of Mini·B supports a 
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relatively superficial disposition of SP-B in lipid bilayers and monolayers in the lung. 
The helical segments of the protein may interact primarily with the polar headgroups of 
the phospholipids and slightly with their acyl chains in the hydrophobic regions of the 
surfactant structures. 
Mini-B contains a total of seven positively charged amino acids while the net 
charge ofSP-B is also+ 7. Five ofthe seven cationic residues are localized in the helical 
regions of Mini-B (Figure 4.15). This can define a preferential electrostatic interaction of 
SP-B terminal helices with anionic phospholipids, such as PG, in both monolayers and 
bilayers. The SP-B - PG interaction has been proposed to promote enrichment of the 
interfacial film with the most surface active phospholipids during compression [16, 72]. 
Selective interaction of SP-B with negatively charged phospholipids could also be 
important for the formation of nonbilayer intermediates required in bilayer-monolayer 
transition [81]. 
Mini-B retained significant surface activity of the native SP-B in treating 
surfactant deficient rats [Waring et al., unpublished]. This indicates that Mini-B preserves 
crucial characteristic properties of the full-length protein. SP-B likely binds 
anionic/zwitterionic phospholipids of lung surfactant to ensure rapid adsorption of the 
material and formation of specific structures that reduce the surface tension at the air-
water interface in alveoli. This ability to bind other molecules is the most fundamental 
property which underlies all the biochemical functions of proteins [ 44]. Binding property 
arises from the complementarity of shape and charge distribution between the other 
molecule and its binding site on the protein and from the arrangement of donors and 
acceptors for hydrogen bonds. Retention of the activity of the full-length protein to a 
significant extent indicates that Mini-B likely contains the binding sites of the native 
SP-B. The two helices of Mini-B likely correspond to the two terminal helices of SP-B 
which are thought to be the active regions of the full-length protein [76]. 
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The conformational features identified from this study provide insight into the 
structural basis of SP-B that determines its function. The present research would also 
provide a primary source of information for any future NMR structural studies of Mini-B 
in lipid micelles mimicking the physiological environment. 
Saposin C 
Saposin B 
Amoebapore (PFP) 
Mini-B 
Figure 4.17 : Structures of the proteins belonging to the Saposin superfamily [diagrams are taken 
from Protein Data Bank]. The structure of Mini-S that was determined in the present research is 
shown at the bottom. The relative orientation of the two helices in Mini-S was not determined 
since HFIP induced only the secondary structure and not the overall 3D structure of the peptide. 
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Chapter 5 
Conclusion 
5.1 Summary and Remarks 
Lung surfactant is a mixture of lipids and proteins that lines the air-water interface 
m alveoli. This material reduces the surface tension generated at the interface to 
extremely low values and thus prevents lung collapse during expiration and eases the 
work of breathing during inspiration. The protein SP-B is an essential component without 
which the surfactant cannot work. It is found as a homodimer in the mammalian lung. 
The 3D structure of this protein is not yet known and hence the structural basis for its 
crucial role is still unresolved. In the present research, the structure and lipid interactions 
of SP-B were probed through studies of smaller fragments of the full-length protein. Use 
of these protein-fragments had two main advantages; firstly, they are biologically active 
and hence definitely contain the functional regions of full-length SP-B and secondly, 
their small sizes allow them to be produced synthetically and facilitates solution NMR 
studies which are hampered by large protein size. 
The structures of SP-BcTERM were determined earlier by Booth et al. in organic 
solvent HFIP and lipid micelles formed from detergent SDS [ 42]. The structures in both 
environments showed that the peptide is mostly a.-helical. In the first phase of present 
research, the conformational and lipid-binding features of SP-BcTERM were studied in 
four other lipid micelle systems. These lipids, namely DPC, LPG, LP A and DHPC, are 
micelle-forming analogs of the physiological phospholipids PC and PG with which the 
native SP-B preferentially interacts. Thus the responses of SP-BcTERM in these lipid 
micelle systems are indicative of the interactions between SP-B and the physiological 
phospholipids. 
SP-BcTERM caused an aggregation of micelles formed from each of the four lipids, 
as indicated by the reduced intensity of the NMR signals and confirmed (at least for DPC) 
by DLS. The NMR spectra also indicated that the peptide took on multiple conformations 
in DPC and LPG micelles, though CD analyses indicated that these multiple 
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conformations remained highly helical. The aggregation was most pronounced for LP A 
micelles. In DHPC, although aggregation was still present, SP-BcTERM took on a well-
defined structure. These studies, together with the previous studies, showed that not all 
micelle types result in aggregation induced by SP-BcTERM in a similar manner. In 
particular, the peptide did not cause any noticeable aggregation of SGS micelles. 
The findings from these investigations demonstrate the ability of SP-BcTERM to 
firmly bind certain lipid molecules analogous to the physiological phospholipids. 
Thereby, this biologically active fragment of SP-B confers on the full-length protein the 
ability to make large-scale lipid rearrangements and maintain the structures at alveolar 
air-water interface at various stages of lung surfactant operation. 
In the second and main phase of present research, the high-resolution structure of 
Mini-B was determined in structure-promoting fluorinated organic solvent HFIP by 
solution NMR. Mini-B, which is anN-terminal- C-terminal construct of the native SP-B, 
was found to consist of two a-helices connected by an unstructured loop. The two helices 
correspond to the terminal helical regions of the full-length protein. These helices are 
amphiphilic in nature because of the localization of the polar and nonpolar residues on 
opposite sides. The two helices are cationic and contain five of the seven positively 
charged amino acids. Both the amphiphilic and cationic properties of Mini-B provide 
important clues on the lipid-protein interactions that are necessary to explain SP-B's 
functional mechanisms. 
The HFIP-induced structure of Mini-B is the first high-resolution structure 
determined for this peptide. This structure will provide a platform for any future 
investigations on the conformational features of Mini-B in lipid mimetic environments. 
Since the peptide demonstrated significant biological activity, it likely consists of the 
most important regions of the full-length protein. Hence, its structure provides vital 
information on the structural features of the native SP-B and the mechanisms underlying 
the function. 
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SP-B is essential for life but the molecular basis for its activity is not yet 
understood. The current research will enhance the ongoing endeavor in defining the 
structural features that lead to SP-B's function. Knowledge of the molecular mechanisms 
involved in the function, in turn, would be of great utility in developing better artificial 
lung surfactants. 
5.2 Future Work 
The structures of SP-BcTERM were determined earlier in organic solvent HFIP and 
micelles composed from the detergent SDS. The first phase of this research explored the 
binding ability of this cationic peptide by inducing aggregation of anionic phospholipids 
LPG and LPA and zwitterionic phospholipid DPC. The peptide, however, took on a well-
defined homogeneous conformation in another zwitterionic environment offered by the 
phospholipid DHPC. Thus, the DHPC micelle system appears to be a potential lipid 
mimetic for future structural studies of SP-B peptides. 
The structure of Mini-B was determined in HFIP in the second and main phase of 
present research. Mini-B was synthesized without the disulfide bonds between the 
cysteines. Presently, work is ongoing to determine the structure of Mini-B with the 
disulfide bonds between the cysteines in the micelle system formed from SDS. Once this 
is done, structures ofMini-B in HFIP and SDS can be compared. 
As the next step, the conformational features of Mini-B can be studied in lipid 
micelles that mimic the physiological environment of SP-B better than SDS, in particular 
DHPC. An exploration of the specific lipid binding ability of this peptide can be studied 
in DPC and LPG micelles as well. The concentrations of the phospholipids used to study 
SP-BcTERM were 150 mM in the present research. For the next study, noting the number 
of lipid molecules required to form a single micelle, the concentrations of peptide and 
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lipid can be chosen such that one peptide molecule be available per lipid micelle. In the 
case of aggregation, DLS experiments can be performed to determine the sizes of the 
aggregated complexes and to compare those with the sizes of the micelles without the 
peptide. 
The final target of the ongoing research is determining the structure of the full-
length SP-B. Hence after structural characterization of Mini-B, efforts can be taken to 
study a larger peptide encompassing more regions of SP-B. One such peptide, named 
Maxi-B, is in the process of being synthesized. Structural studies of this peptide, once it 
is available, can begin in HFIP environment to provide the first detailed structural 
characterization. Later on, more physiologically relevant structures can be determined in 
lipid micelle mimetics. 
A clear understanding of SP-B's structural characteristics will help unveil the 
structural basis for its functional properties. This knowledge will contribute directly into 
the ongoing endeavor to obtain better surfactant replacement treatments. 
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